

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>HIV-associated neurocognitive disorders: recent... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-312/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-312" />
    
            <meta name="description" content="Read the original article in full on F1000Research: HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment" />
    
            <meta name="og:title" content="F1000Research Article: HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.">
            <meta name="og:description" content="Read the latest article version by Antonia Carroll, Bruce Brew, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11478">
            <meta name="article-id" content="10651">
            <meta name="dc.title" content="HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment">
            <meta name="dc.description" content="HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the &ldquo;gold standard&rdquo; of diagnosis; however, this is time consuming and costly in a resource-poor environment. Recently developed screening tools, such as CogState and the revised HIV dementia scale, have very good sensitivity and specificity in the more severe stages of HAND. However, questions remain regarding the utility of, optimal population for, and insensitivity of tests in mild HAND. 
Recognition of ongoing viral persistence and the inflammatory milieu in the central nervous system (CNS) has advanced our understanding of the pathogenesis of HAND and facilitated the development of biomarkers of CNS disease. The importance of the monocyte-macrophage lineage cell and the astrocyte as viral reservoirs, HIV viral proteins, self-perpetuating CNS inflammation, and CCR5 chemokine receptor neurotropism has been identified. Whilst biomarkers demonstrate monocyte activation, inflammation, and neuronal injury, they remain limited in their clinical utility. The improved understanding of pathogenic mechanisms has led to novel approaches to the treatment of HAND; however, despite these advances, the optimal management is still undefined.">
            <meta name="dc.subject" content="HIV-associated neurocognitive disorders, HAND, HIV, CNS, HAART">
            <meta name="dc.creator" content="Carroll, Antonia">
            <meta name="dc.creator" content="Brew, Bruce">
            <meta name="dc.date" content="2017/03/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10651.1">
            <meta name="dc.source" content="F1000Research 2017 6:312">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="HIV-associated neurocognitive disorders">
            <meta name="prism.keyword" content=" HAND">
            <meta name="prism.keyword" content=" HIV">
            <meta name="prism.keyword" content=" CNS">
            <meta name="prism.keyword" content=" HAART">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/03/23">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="312">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10651.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-312">
            <meta name="citation_title" content="HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment">
            <meta name="citation_abstract" content="HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the &ldquo;gold standard&rdquo; of diagnosis; however, this is time consuming and costly in a resource-poor environment. Recently developed screening tools, such as CogState and the revised HIV dementia scale, have very good sensitivity and specificity in the more severe stages of HAND. However, questions remain regarding the utility of, optimal population for, and insensitivity of tests in mild HAND. 
Recognition of ongoing viral persistence and the inflammatory milieu in the central nervous system (CNS) has advanced our understanding of the pathogenesis of HAND and facilitated the development of biomarkers of CNS disease. The importance of the monocyte-macrophage lineage cell and the astrocyte as viral reservoirs, HIV viral proteins, self-perpetuating CNS inflammation, and CCR5 chemokine receptor neurotropism has been identified. Whilst biomarkers demonstrate monocyte activation, inflammation, and neuronal injury, they remain limited in their clinical utility. The improved understanding of pathogenic mechanisms has led to novel approaches to the treatment of HAND; however, despite these advances, the optimal management is still undefined.">
            <meta name="citation_description" content="HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the &ldquo;gold standard&rdquo; of diagnosis; however, this is time consuming and costly in a resource-poor environment. Recently developed screening tools, such as CogState and the revised HIV dementia scale, have very good sensitivity and specificity in the more severe stages of HAND. However, questions remain regarding the utility of, optimal population for, and insensitivity of tests in mild HAND. 
Recognition of ongoing viral persistence and the inflammatory milieu in the central nervous system (CNS) has advanced our understanding of the pathogenesis of HAND and facilitated the development of biomarkers of CNS disease. The importance of the monocyte-macrophage lineage cell and the astrocyte as viral reservoirs, HIV viral proteins, self-perpetuating CNS inflammation, and CCR5 chemokine receptor neurotropism has been identified. Whilst biomarkers demonstrate monocyte activation, inflammation, and neuronal injury, they remain limited in their clinical utility. The improved understanding of pathogenic mechanisms has led to novel approaches to the treatment of HAND; however, despite these advances, the optimal management is still undefined.">
            <meta name="citation_keywords" content="HIV-associated neurocognitive disorders, HAND, HIV, CNS, HAART">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Antonia Carroll">
            <meta name="citation_author_institution" content="Department of Neurology, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia">
            <meta name="citation_author_institution" content="University of New South Wales, St. Vincent&rsquo;s Clinical School, Delacy Building, Victoria Street, Darlinghurst, Sydney, Australia">
            <meta name="citation_author" content="Bruce Brew">
            <meta name="citation_author_institution" content="Department of Neurology, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia">
            <meta name="citation_author_institution" content="Peter Duncan Neurosciences Unit, St Vincent&rsquo;s Centre for Applied Medical Research, St Vincent&rsquo;s Hospital, Sydney, Australia">
            <meta name="citation_author_institution" content="Department of HIV Medicine, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia">
            <meta name="citation_author_institution" content="University of New South Wales, St. Vincent&rsquo;s Clinical School, Delacy Building, Victoria Street, Darlinghurst, Sydney, Australia">
            <meta name="citation_publication_date" content="2017/03/23">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="312">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10651.1">
            <meta name="citation_firstpage" content="312">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-312/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-312.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11478 /> <input type=hidden id=articleId name=articleId value=10651 /> <input type=hidden id=xmlUrl value="/articles/6-312/v1/xml"/> <input type=hidden id=xmlFileName value="-6-312-v1.xml"> <input type=hidden id=article_uuid value=ae3c5a43-46b5-46dd-823e-12eed64a5fd3 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10651.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10651.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-312"
  },
  "headline": "HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment",
  "datePublished": "2017-03-23T15:55:50",
  "dateModified": "2017-03-23T15:55:50",
  "author": [
    {
      "@type": "Person",
      "name": "Antonia Carroll"
    },    {
      "@type": "Person",
      "name": "Bruce Brew"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the &ldquo;gold standard&rdquo; of diagnosis; however, this is time consuming and costly in a resource-poor environment. Recently developed screening tools, such as CogState and the revised HIV dementia scale, have very good sensitivity and specificity in the more severe stages of HAND. However, questions remain regarding the utility of, optimal population for, and insensitivity of tests in mild HAND.
Recognition of ongoing viral persistence and the inflammatory milieu in the central nervous system (CNS) has advanced our understanding of the pathogenesis of HAND and facilitated the development of biomarkers of CNS disease. The importance of the monocyte-macrophage lineage cell and the astrocyte as viral reservoirs, HIV viral proteins, self-perpetuating CNS inflammation, and CCR5 chemokine receptor neurotropism has been identified. Whilst biomarkers demonstrate monocyte activation, inflammation, and neuronal injury, they remain limited in their clinical utility. The improved understanding of pathogenic mechanisms has led to novel approaches to the treatment of HAND; however, despite these advances, the optimal management is still undefined."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-312.html",
            "name": "HIV-associated neurocognitive disorders: recent advances in pathogenesis,..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> HIV-associated neurocognitive disorders: recent advances in pathogenesis,... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11478 data-id=10651 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10651.1" data-recommended="" data-doi="10.12688/f1000research.10651.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-312/v1/pdf?article_uuid=ae3c5a43-46b5-46dd-823e-12eed64a5fd3" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10651-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10651-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10651-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Carroll A and Brew B. HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):312 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10651.1" target=_blank>https://doi.org/10.12688/f1000research.10651.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10651-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10651 id=track-article-signin-10651 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10651?target=/articles/6-312.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11478 /> <input name=articleId type=hidden value=10651 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Antonia Carroll<a href="https://orcid.org/0000-0002-1738-9580" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1738-9580</div><sup>1,4</sup>,&nbsp;</span><span class=""><a href="mailto:B.Brew@unsw.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bruce Brew</span></a><sup>1-4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Antonia Carroll<a href="http://orcid.org/0000-0002-1738-9580" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1738-9580</div><sup>1,4</sup>,&nbsp;</span><span class=""><a href="mailto:B.Brew@unsw.edu.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bruce Brew</span></a><sup>1-4</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Mar 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10651.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Neurology, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <sup>2</sup> Peter Duncan Neurosciences Unit, St Vincent&rsquo;s Centre for Applied Medical Research, St Vincent&rsquo;s Hospital, Sydney, Australia<br/> <sup>3</sup> Department of HIV Medicine, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <sup>4</sup> University of New South Wales, St. Vincent&rsquo;s Clinical School, Delacy Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21338-21132></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=5136-21130></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21340-21131></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21339-21133></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> HIV-associated neurocognitive disorders (HAND) remain prevalent despite plasma viral suppression by antiretroviral agents. In fact, the prevalence of milder subtypes of cognitive impairment is increasing. Neuropsychologic testing remains the gold standard of diagnosis; however, this is time consuming and costly in a resource-poor environment. Recently developed screening tools, such as CogState and the revised HIV dementia scale, have very good sensitivity and specificity in the more severe stages of HAND. However, questions remain regarding the utility of, optimal population for, and insensitivity of tests in mild HAND.<br/> Recognition of ongoing viral persistence and the inflammatory milieu in the central nervous system (CNS) has advanced our understanding of the pathogenesis of HAND and facilitated the development of biomarkers of CNS disease. The importance of the monocyte-macrophage lineage cell and the astrocyte as viral reservoirs, HIV viral proteins, self-perpetuating CNS inflammation, and CCR5 chemokine receptor neurotropism has been identified. Whilst biomarkers demonstrate monocyte activation, inflammation, and neuronal injury, they remain limited in their clinical utility. The improved understanding of pathogenic mechanisms has led to novel approaches to the treatment of HAND; however, despite these advances, the optimal management is still undefined. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> HIV-associated neurocognitive disorders, HAND, HIV, CNS, HAART </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Bruce Brew (<a href="mailto:B.Brew@unsw.edu.au">B.Brew@unsw.edu.au</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Bruce Brew </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Carroll A and Brew B. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Carroll A and Brew B. HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.10651.1" target=_blank>https://doi.org/10.12688/f1000research.10651.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Mar 2017, <b>6</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.10651.1" target=_blank>https://doi.org/10.12688/f1000research.10651.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Mar 2017, <b>6</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.10651.1" target=_blank>https://doi.org/10.12688/f1000research.10651.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d16334e190>Introduction</h2><p class="" id=d16334e193>In the era of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV), there has been a dramatic shift in neurologic sequelae of the disease. Opportunistic infections associated with severe immunodeficiency are now much less prevalent, but neurologic complications associated with chronic infection, treatments, immune reconstitution, and concurrent comorbidities are increasing. Despite HAART, HIV-associated neurocognitive disorders (HAND) remain a chronic issue, with significant effects on an individuals ability to perform activities of daily living, quality of life, employment, medication adherence, and survival<sup><a href="#ref-1">1</a><a href="#ref-5">5</a></sup>.</p><p class="" id=d16334e203>HAND is a common disease with variable reported prevalence in different populations (2069%)<sup><a href="#ref-6">6</a><a href="#ref-14">14</a></sup>. It is most commonly seen in advanced stages of HIV/AIDS; however, HAND can also occur in asymptomatic HIV infection<sup><a href="#ref-12">12</a>,<a href="#ref-15">15</a><a href="#ref-18">18</a></sup>. It is critically important, though, to recognize that HAND occurs in only <i>some</i> patients  the majority of patients who are virally suppressed on HAART will not develop HAND. HAND is grouped by the 2007 Frascati criteria into three categories of increasing severity of cognitive impairment: asymptomatic neurocognitive impairment (ANI), mild neurocognitive dementia (MND), and HIV-associated dementia (HAD)<sup><a href="#ref-19">19</a></sup>. The category is assigned on the basis of clinical features, especially those related to daily functioning, exclusion of alternative causes, and neuropsychological testing.</p><p class="" id=d16334e230>HAART has transformed HIV treatment, controlling plasma viremia and allowing the life expectancy of HIV-positive patients to approach that of age-matched controls<sup><a href="#ref-20">20</a></sup>. While HAART has reduced the incidence of all categories of moderate to severe dementia (HAD: 7% in 1989 to 1% in 2000)<sup><a href="#ref-21">21</a></sup>, there is a continued and increasing prevalence of milder subtypes of HAND  ANI and MND  despite sustained virologic control<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a>,<a href="#ref-17">17</a>,<a href="#ref-22">22</a></sup>. ANI now accounts for between 33 and 60% of all HAND<sup><a href="#ref-12">12</a>,<a href="#ref-14">14</a>,<a href="#ref-17">17</a></sup>. Thus, HAART has significantly impacted upon only the more severe forms of HAND, but one would expect these potent antiretrovirals (ARVs) to have a more profound effect on milder HAND. We have termed this curious situation the therapeutic paradox. The natural history of HAND in the context of viral suppression has also been clarified recently. Most patients who continue to be virally suppressed remain stable, but some improve and a small number deteriorate<sup><a href="#ref-23">23</a></sup>. This is best termed as the <i>activity</i> of HAND.</p><p class="" id=d16334e272>Despite the terminology, ANI is not without consequence, with negative impacts on quality of life, medication adherence, and employment<sup><a href="#ref-1">1</a><a href="#ref-5">5</a></sup>, and some studies show progression to MND/HAD<sup><a href="#ref-14">14</a>,<a href="#ref-24">24</a></sup>. As such, HAND remains an important ongoing area of clinical research in the context of increasing worldwide impact of HAND as HAART becomes more prevalent. This update summarizes recent advances in central nervous system (CNS) HIV disease, including screening strategies for HAND, its pathogenesis, biomarkers for HAND, and its treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16334e292>Screening</h2><p class="" id=d16334e295>The uncertainty in the natural history of HAND raises the question of whether screening for HAND is beneficial, with some groups suggesting that screening could lead to unnecessary, costly, invasive procedures in a climate of limited clinical resources. For screening to be beneficial, tests with adequate sensitivity and specificity are required, as well as management that alters the course of disease, preventing progression from early stages to severe dementia. While progress has recently been made with regard to these requirements (e.g. <a href="#ref-25">25</a><a href="#ref-27">27</a>), at the present time neither of these criteria are definitively met.</p><p class="" id=d16334e304>Multiple HIV-specific factors have been associated with cognitive decline. Longer duration of HIV, nadir CD4<sup>+</sup> T cell count, ongoing viremia, and replication in the CNS and periphery are all associated with cognitive decline<sup><a href="#ref-9">9</a>,<a href="#ref-14">14</a>,<a href="#ref-28">28</a><a href="#ref-31">31</a></sup>. In particular, the risk of HAND increases as CD4<sup>+</sup> counts decline below 350 cells/L and with higher plasma HIV viral loads<sup><a href="#ref-30">30</a></sup>. These HIV-specific factors are potentially preventable or treatable with alterations to medication regimes, suggesting that early intervention may be able to reduce the risk of HAND; however, this hypothesis is yet to be confirmed (see the section titled Treatment). As a result, we feel that improved screening methods to identify early those developing HAND and, in particular, high-risk individuals remains important for our ability to combat HAND in the future.</p><p class="" id=d16334e330>Screening tests capturing mild cognitive impairments are currently being investigated. A newly designed computerized battery, CogState, assessing five relevant cognitive domains has recently been assessed in Australia in HIV-positive individuals relative to age- and education-matched controls<sup><a href="#ref-26">26</a></sup>. Comparison with neuropsychological testing resulted in a sensitivity of 73% and specificity of 82%, with a correct classification rate of 79%<sup><a href="#ref-26">26</a></sup>. In the MND/HAD subgroup, the sensitivity and specificity improved dramatically to 100% and 98%, respectively<sup><a href="#ref-26">26</a></sup>. This screening method is suitable for application by non-specialists and may assist with detecting patients requiring more in-depth neuropsychological testing, hence guiding limited resources in this setting.</p><p class="" id=d16334e345>While this test does not improve screening for the ANI category of patients, these individuals could be monitored with longitudinal re-screening whilst controlling and treating alternate risk factors for cognitive decline<sup><a href="#ref-26">26</a></sup>. Further studies will be required to assess the validity of this screening test in longitudinal studies. Thus far, longitudinal decline, as measured with repeat assessments of the HIV dementia scale (HDS), was reliable in the retest setting; however, similar to CogState, this technique was also able to robustly detect only moderate to severe cognitive decline<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d16334e357>Despite the limitations defined above, the guidelines currently suggest that screening for cognitive impairment should be performed in HIV-seropositive individuals; however, no consensus has been reached regarding the time point or screening tools that should be used<sup><a href="#ref-32">32</a><a href="#ref-35">35</a></sup>. Screening has not yet been universally adopted by practicing clinicians. Nonetheless, at present, it would seem reasonable for screening to target those individuals at risk of HAND rather than the general HIV population. Such risk factors have been discussed in the second paragraph of this section. It is not clear yet whether some or all of these should be used as red flags for screening, but at least they serve as a starting point.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16334e370>Pathogenesis and the evolution of biomarkers</h2><p class="" id=d16334e373>The therapeutic paradox has called into question our understanding of the pathophysiology of HAND. Treatments targeting these mechanisms may be the key to effective treatment in the future. While an in-depth review of the pathophysiology of HIV in the CNS is beyond the scope of this review, a few key advances have been identified in recent years, including the importance of monocytemacrophage and astrocyte viral reservoirs, chronic inflammation in the CNS, HIV viral proteins, and CCR5 chemokine receptor neurotropism.</p><div class=section><a name=d16334e376 class=n-a></a><h3 class=section-title>The brain as a viral reservoir</h3><p class="" id=d16334e381>The concept of quiescent viral reservoirs, systemically or in the CNS, has emerged as a barrier to HIV eradication in the post-HAART era<sup><a href="#ref-36">36</a></sup>. Monocytes and macrophages, in both the CNS and the periphery, express co-receptors necessary for HIV infection, are infected early in the course of disease, are long-living, do not die as a consequence of HIV infection or immune surveillance, and hence can become viral reservoirs for HIV<sup><a href="#ref-37">37</a><a href="#ref-41">41</a></sup>. Furthermore, ARV entry into the brain can be variable because of the bloodbrain barrier, and ARV efficacy as well as the ability of agents to reverse latency in brain cells such as microglia and particularly astrocytes is at best limited<sup><a href="#ref-42">42</a></sup>. These factors point to the brain as a sanctuary site, further reinforcing the brain as a likely viral reservoir. Probable latent brain infection in macrophages, astrocytes, and other glial cells has been demonstrated in multiple neuropathologic and <i>in vitro</i> studies<sup><a href="#ref-43">43</a><a href="#ref-50">50</a></sup>. The issue remains controversial, though, as some consider that the demonstration of such virus reflects only the phagocytic function of those cells. Further, as yet, the virus in such cells has not been demonstrated to be replication competent, with the exception of macrophages, though the study used animal models<sup><a href="#ref-51">51</a></sup>. Nonetheless, one study found that after 10 years of suppressive antiretroviral therapy (ART) in the plasma, low levels of HIV RNA could still be detected in the cerebrospinal fluid (CSF)  that is, viral escape  with associated evidence of immune activation, thereby emphasizing the brain as both a sanctuary site and a viral reservoir<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d16334e418>Further support for the brain as a viral reservoir comes from a recent study of simian immunodeficiency virus (SIV)-infected macaques that were continuously virally suppressed with CNS-penetrant HAART. When latency-reversing agents were administered, there was reactivation of virus in the macaque brain<sup><a href="#ref-53">53</a></sup>. This resulted in increases in CSF viral load, 10 times higher than plasma, and increased CNS immune activation and neuronal damage markers, likely contributing to a harmful CNS inflammatory response<sup><a href="#ref-53">53</a></sup>. The most prevalent SIV genotype in the CSF was novel compared with peripheral genotypes, suggesting that distinct genomes that persisted in the CNS compartment were amplified despite long-term peripheral viral suppression<sup><a href="#ref-53">53</a></sup>. Similarly, in humans, it is relatively common to find different genotypes of HIV in the CNS and periphery, again demonstrating compartmentalization in the CNS and its role as a reservoir<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>.</p></div><div class=section><a name=d16334e441 class=n-a></a><h3 class=section-title>Monocyte populations and biomarkers</h3><p class="" id=d16334e446>Direct evidence of infected monocytes entering the brain has not been demonstrated in humans; however, animal models have demonstrated peripheral monocyte trafficking to the CNS in SIV infection<sup><a href="#ref-56">56</a></sup>. HIV viral load and proviral HIV DNA in plasma mononuclear cells have been linked to disease progression, AIDS development, and HAND in HAART-nave advanced infection and proviral DNA in virally suppressed individuals<sup><a href="#ref-57">57</a><a href="#ref-59">59</a></sup>. Interestingly, a recent study identified that levels of HIV DNA in peripheral mononuclear cells were not associated with HAND in virally suppressed HIV-positive individuals on stable HAART regimens. Instead, an increase in monocyte HIV-positive reservoir size was associated with progression of HAND, in particular in the HAD subgroup<sup><a href="#ref-60">60</a></sup>. These papers raise a crucial issue in HAND pathogenesis: at what point do systemic factors become less important compared to brain-related factors? In other words, when does systemic HIV disease metastasize to the brain, at that point making it a truly brain-autonomous problem no longer driven by systemic disease?</p><p class="" id=d16334e464>In HIV, the phenotypic subpopulations of monocytes are altered, resulting in increased circulating CD16<sup>+</sup> monocytes instead of the usually prevalent CD14<sup>+</sup>CD16<sup></sup> populations found in normal controls<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. CD16<sup>+</sup> cells can be infected by HIV, in part due to differences in host restriction factor expression (APOBEC isoforms and SAMDH1) allowing HIV replication<sup><a href="#ref-63">63</a><a href="#ref-68">68</a></sup>. The proportion of CD16<sup>+</sup> monocytes in the total population is associated with uncontrolled viremia (&gt;400 copies/mL), reduced by adherence to ART, and linked to disease progression<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a>,<a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. Increased proportions and absolute numbers of CD16<sup>+</sup> monocytes are more strongly associated with HAND than with the CSF viral load or proportion of HIV-infected cells in the CNS; hence, measurement of CD16<sup>+</sup> populations, CD14<sup>+</sup>/CD16<sup>+</sup> ratio, and high HIV DNA levels in CD16<sup>+</sup> cells may be used as biomarkers of disease and correlate with neurocognitive dysfunction<sup><a href="#ref-71">71</a><a href="#ref-75">75</a></sup>.</p><p class="" id=d16334e533>Alternate monocyte biomarkers have also been identified. CD163 is a hemoglobinhaptoglobin scavenger receptor found exclusively on monocytes and macrophages<sup><a href="#ref-76">76</a><a href="#ref-80">80</a></sup>. When monocytes are activated by lipopolysaccharide, Fc<i></i> receptors crosslink or oxidative stress occurs, CD163 is shed as soluble CD163 (sCD163) to reduce inflammatory cell activation and cytokine release<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a>,<a href="#ref-81">81</a><a href="#ref-83">83</a></sup>. Expression of CD163 is higher on CD16<sup>+</sup> monocytes<sup><a href="#ref-84">84</a></sup>. Plasma sCD163 is elevated in individuals with HIV duration greater than one year, and HAART therapy reduces sCD163 commensurate with HIV RNA levels; however, sCD163 levels remain significantly higher than in controls, suggesting ongoing low-level monocyte activation<sup><a href="#ref-83">83</a></sup>. Follow-up clinical studies demonstrate that higher levels of sCD163 occur in HAND populations, in particular the MND/HAD groups, compared with those who were cognitively unimpaired<sup><a href="#ref-85">85</a></sup>. These results suggest that sCD163 is a novel marker of macrophage-mediated disease activity in HIV, systemically and in the CNS. However, it is not specific for HIV, nor does it distinguish the duration of infection or HAND subtype.</p><p class="" id=d16334e575>Another marker of monocyte activation, sCD14, a soluble monocyte lipopolysaccharide receptor, is similar to sCD163 in that levels are higher in early and chronic HIV infection than in HIV-negative controls<sup><a href="#ref-83">83</a></sup>. However, sCD14 levels were not reduced by treatment with HAART and were significantly increased after treatment with HAART in early HIV<sup><a href="#ref-83">83</a></sup>. Plasma and CSF sCD163 correlates with sCD14<sup><a href="#ref-83">83</a>,<a href="#ref-85">85</a></sup>. However, despite this, sCD14 has had variable associations with HAND severity<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. Alternate monocyte biomarkers, such as CSF CCL2, correlate with HAND severity and risk of progression as well as markers of inflammation<sup><a href="#ref-87">87</a>,<a href="#ref-88">88</a></sup>. The comparative clinical utility of these biomarkers requires further study.</p></div><div class=section><a name=d16334e608 class=n-a></a><h3 class=section-title>Chronic inflammation and HIV proteins</h3><p class="" id=d16334e613>The inflammatory milieu, as a potential contributor to HAND, has become an interesting area of research. It is increasingly recognized that low-level latent infection in HIV and its comorbidities (e.g. metabolic syndrome, drug use, and hepatitis C) as well as aging can lead to chronic low-grade immune activation and inflammation<sup><a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>. Sustained CNS inflammation occurring during HAART may be due to latent and low-level infection in the CSF meningeal compartment and possibly brain (viral escape), priming of microglia and macrophages due to circulating products translocated from the gut, altered neuronal and synaptic function, contributions from the metabolic syndrome, and possible ART-related toxicity.</p><p class="" id=d16334e623>The macrophage and microglia biomarker of immune activation, neopterin, is elevated in most HIV seropositive individuals, with levels declining after commencement of HAART. Low viral persistence in the CNS, as measured by CSF HIV RNA, is significantly correlated with CSF neopterin elevation<sup><a href="#ref-91">91</a></sup>. Neopterin correlates with HAND severity in ART-nave individuals and predicts the development of HAND; however, its utility in the HAART era is not clear<sup><a href="#ref-92">92</a><a href="#ref-94">94</a></sup>.</p><p class="" id=d16334e637>Inflammatory cytokine secretion by infected monocytes causes a cascade, with compounding effects due to positive feedback on gene transcription<sup><a href="#ref-95">95</a></sup>. This chronic inflammation is probably exacerbated by HIV component proteins expressed in infected cells (especially monocytes), such as Vpr, Tat, Nef, and gp120, which further activate inflammatory pathways, leading directly to neural toxicity<sup><a href="#ref-96">96</a><a href="#ref-99">99</a></sup>. However, chronic inflammation in latent HIV infection with suppressed HIV RNA may be caused by deregulation of inflammatory cascades by transcriptional regulators, such as BCL11B, with resultant silencing of integrated virus<sup><a href="#ref-43">43</a></sup>. Conversely, in HIV-encephalitis (HIVE), reduced transcriptional regulation leads to re-emergence of HIV RNA in CSF and brain<sup><a href="#ref-43">43</a></sup>. This suggests that HAND with viral suppression may be driven by viral components, such as Tat and Nef, whereas HAND without viral suppression may be fuelled by whole virus, in particular envelope proteins. This is an attractive potential explanation for HAND in the context of viral suppression, as current HAART does not target the immediate post-integration transcription stage of the HIV replication cycle, allowing the continued production of Tat, Nef, and Vpr.</p><p class="" id=d16334e659>Tat and Nef have been found to affect endothelial activation and dysfunction, leading to cardiovascular disease<sup><a href="#ref-100">100</a></sup>. Tat transcriptionally deregulates genes and induces cytokine activation of IL-17 pathways, leading to a proinflammatory state with direct neurotoxicity<sup><a href="#ref-101">101</a></sup>. In addition, it is soluble, able to exit the infected cell, and can affect neighboring cells<sup><a href="#ref-101">101</a></sup>. Thus, measurement of Tat is a plausible biomarker for neural damage in HAND. However, CSF Tat does not correlate directly with HAND severity, possibly because it is only intermittently produced, or there may be difficulties with the lower limit of detection in current assays<sup><a href="#ref-102">102</a></sup>. In the future, antisense oligonucleotides and monoclonal antibodies could be utilized to enhance the efficacy of HAART<sup><a href="#ref-103">103</a></sup>.</p></div><div class=section><a name=d16334e684 class=n-a></a><h3 class=section-title>CCR5 chemokine receptor neurotropism</h3><p class="" id=d16334e689>Viral envelope glycoproteins can fuse with only those cells expressing both CD4 and an HIV co-receptor, of which CCR5 has been identified as the most important for microglia and CNS macrophages<sup><a href="#ref-104">104</a>,<a href="#ref-105">105</a></sup>. CCR5 receptors are upregulated on activated CD4<sup>+</sup> and CD8<sup>+</sup> T cells, enhancing antigen-presenting cell interaction, T cell trafficking into tissues, and cytokine production<sup><a href="#ref-106">106</a></sup>. In response to infection or inflammation, monocytes, microglia, astrocytes, and neurons express CCR5 ligands, which increase the migration of CCR5<sup>+</sup> T cells into the CNS<sup><a href="#ref-106">106</a></sup>. Locally, these effector T cells secrete CCR5 ligands, which amplify the immune response<sup><a href="#ref-106">106</a></sup>. A subset of CCR5-tropic viruses have been found to be highly fusogenic, requiring lower expression levels of CCR5 and CD4 to infect cells, leading to greater apoptosis<sup><a href="#ref-107">107</a></sup>. There is now good evidence that the vast majority of HIV strains in the brain are CCR5 tropic<sup><a href="#ref-108">108</a></sup>. Given the intrinsic role of CCR5 in CNS disease, it is suggested that CCR5 antagonists, such as maraviroc, may be able to reduce the migration and then activation of effector CD8<sup>+</sup> T cells in the CNS and hence reduce the neurocognitive sequelae of HIV<sup><a href="#ref-106">106</a></sup>. This is now being assessed (see the section titled Treatment).</p></div><div class=section><a name=d16334e737 class=n-a></a><h3 class=section-title>Biomarkers of HIV replication</h3><p class="" id=d16334e742>While quantification of CSF HIV DNA as a biomarker of HAND is both impracticable and insensitive<sup><a href="#ref-109">109</a></sup>, measurement of HIV RNA expression in CSF is more robust. In the pre-HAART era and ARV-nave population, HIV RNA in blood is independently associated with cognitive impairment<sup><a href="#ref-110">110</a></sup>, high levels have been associated with HAD in individuals with advanced immunosuppression, and a decrease in HIV RNA levels has been correlated with improvements in cognitive measures<sup><a href="#ref-111">111</a><a href="#ref-115">115</a></sup>. While these factors suggest that HIV RNA level can be a useful biomarker in HAND, it is by no means a perfect marker; its utility in the HAART era is less well established. CSF HIV RNA levels may not accurately reflect HIV replication in brain parenchyma, though single copy assay techniques hold some promise.</p></div><div class=section><a name=d16334e761 class=n-a></a><h3 class=section-title>Biomarkers of neural injury</h3><p class="" id=d16334e766>Biomarkers of neural damage would be expected to correlate most closely with HAND. CSF neurofilament light chain (NFL), a component of myelinated axons, has recently been identified as a sensitive biomarker of neuronal injury in multiple neurodegenerative diseases<sup><a href="#ref-116">116</a><a href="#ref-118">118</a></sup>. In HIV, CSF NFL is increased in patients with and without HAND, with levels higher in HAND and increasing as HIV disease advances, suggesting early neuronal injury<sup><a href="#ref-116">116</a></sup>. CSF NFL concentrations appear to predict the development of HAD, with levels increasing 12 years before symptoms develop<sup><a href="#ref-119">119</a></sup>. However, NFL levels are not sensitive in the detection of mild disease, in particular when virally suppressed<sup><a href="#ref-118">118</a></sup>. Newer ultrasensitive plasma assays for NFL are highly correlated with CSF NFL concentrations<sup><a href="#ref-117">117</a></sup>. NFL levels in plasma and CSF increase with reducing CD4 counts and increasing plasma RNA viral loads in asymptomatic individuals, correlate with HAND severity, reaching the highest values in HAD, and are reduced by HAART<sup><a href="#ref-117">117</a>,<a href="#ref-118">118</a>,<a href="#ref-120">120</a></sup>. NFL is significantly correlated with sCD163 and sCD14, suggesting that CNS monocyte activation is directly linked with neuronal injury in HAND<sup><a href="#ref-118">118</a></sup>. Plasma NFL, although not specific, may be an emerging sensitive, non-invasive assay for HAND, especially as the sensitivity of assays increases.</p><p class="" id=d16334e807>Other biomarkers of neural damage such as tau and CSF/plasma albumin ratios, reflecting bloodbrain barrier integrity, correlate with HAD and in some studies CSF neopterin<sup><a href="#ref-121">121</a><a href="#ref-123">123</a></sup>. These, however, are significantly reduced in the setting of HAART and hence are less useful in the clinical setting of HAND with viral suppression<sup><a href="#ref-121">121</a></sup>. In addition, non-invasive quantitative MRI techniques can reflect neuroinflammation and neuronal injury. A recent study demonstrated early reductions in parenchymal volume, enlargement of the brainstem and third ventricle, diffusion alterations in the caudate, altered white matter integrity in the corpus callosum, and brain metabolite changes reflecting neural injury within 100 days of seroconversion<sup><a href="#ref-124">124</a></sup>.</p><p class="" id=d16334e825>An additional emerging area of interest is microRNAs, the non-coding RNA molecules which regulate gene expression. Specific subtypes miR125b and 146a have a role in microglial infection and cell death<sup><a href="#ref-125">125</a></sup>. In a small study of 10 patients, nine with HAND, these microRNAs correlated with HIVE; however, the interaction with ART and viral suppression has yet to be elucidated<sup><a href="#ref-125">125</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16334e840>Treatment</h2><p class="" id=d16334e843>Recent studies in HIV treatment have attempted to answer three main questions: firstly, is there a role for neuroHAART to improve CNS penetration and concentrations of ARVs? Secondly, is there a role for HAART intensification for HAND in the context of viral suppression? And, thirdly, can HAND be reduced by earlier HAART initiation?</p><div class=section><a name=d16334e846 class=n-a></a><h3 class=section-title>CNS penetration by HAART</h3><p class="" id=d16334e851>The CNS penetration effectiveness (CPE) score was proposed in order to rank drug penetration and efficacy in the CNS<sup><a href="#ref-126">126</a></sup>. The CPE score has been supported in most studies, where treatment regimens with a higher CPE score generally have lower rates of HIV RNA detectible in CSF<sup><a href="#ref-127">127</a>,<a href="#ref-128">128</a></sup>. However, the issue of the utility of the CPE score remains controversial. Indeed, the CPE score is limited by its categorical scoring, unclear weighting of each criterion (pharmacokinetic, chemical properties, etc.), and lack of consideration of toxic effects or drug interactions. Furthermore, the CPE score relies on CSF drug concentrations, which may not reflect the brain parenchymal pharmacokinetics, and efficacy in glial cells is not considered, primarily due to limited data availability.</p><p class="" id=d16334e865>To assess this latter point, recent studies assessing the efficacy of current CNS-penetrating ARVs in astrocytes and macrophage-lineage cells have been performed using <i>in vitro</i> models of infection<sup><a href="#ref-42">42</a>,<a href="#ref-129">129</a></sup>. All of the agents tested could inhibit HIV infection in macrophages with concentrations typically found in CSF<sup><a href="#ref-42">42</a></sup>. Similar results were found in astrocytes, except for lamivudine, stavudine, and zidovudine, which required between 12- and 187-fold greater concentrations than are achievable in the CSF<sup><a href="#ref-42">42</a></sup>. These results indicate that these drugs may not adequately treat astrocyte reservoirs and suggest that these agents should not be utilized in CNS-penetrating (NeuroHAART) regimens.</p><p class="" id=d16334e886>The interaction between improved NeuroHAART, commonly defined by CPE score, and clinical efficacy has not been clearly elucidated. A recent systematic review found only six methodologically sound and two sufficiently powered studies that attempted to answer this question<sup><a href="#ref-130">130</a></sup>. Utilizing these more rigorous studies, it was concluded that a regimen with higher CNS penetration probably improved both neurocognitive function and HIV CSF RNA concentrations<sup><a href="#ref-130">130</a></sup>. Subsequently, a multisite randomized controlled trial has been performed which showed no benefit for a NeuroHAART regimen<sup><a href="#ref-131">131</a></sup>. However, there was an imbalance at entry for CD4 nadir and hepatitis C status, factors which are known to influence neurocognition. Also, it is known that HAND patients may continue to improve on a stable HAART regimen for approximately 1 year from regimen commencement; the trial requirement for stability for only 8 weeks may have been a further confounding factor. As a result, there remain no definitive HAART guidelines for HAND. Further investigations with randomized controlled trials addressing the latter shortcomings are needed<sup><a href="#ref-130">130</a></sup>.</p></div><div class=section><a name=d16334e906 class=n-a></a><h3 class=section-title>HAART intensification for HAND in the context of viral suppression</h3><p class="" id=d16334e911>Recent advances suggest that CCR5 receptor interactions with CNS reservoir cells are intrinsically linked with CNS HIV and HAND. Maraviroc, a CCR5 receptor antagonist, is a target for HAART intensification, as it has adequate CSF penetration, has low rates of resistance, inhibits CNS viral replication, including in monocyte/macrophage cells, and has anti-inflammatory properties in the CNS<sup><a href="#ref-132">132</a><a href="#ref-137">137</a></sup>. Maraviroc acts by blocking HIV entry into cells, hence restricting virion replication and indirectly inhibiting immediate post-integration viral protein production, which probably drives the CNS inflammatory milieu<sup><a href="#ref-96">96</a><a href="#ref-99">99</a>,<a href="#ref-138">138</a></sup>. A recent prospective, open-label pilot randomized controlled trial in individuals with viral suppression and stable ART for 12 months found maraviroc-intensified HAART improved global neurocognitive performance at both 6 and 12 months without significant side effects<sup><a href="#ref-27">27</a></sup>. In the future, large randomized controlled studies will be necessary to confirm these findings; however, this suggests that maraviroc intensification of HAART could be an option for the clinical management of HAND occurring in the context of viral suppression.</p></div><div class=section><a name=d16334e936 class=n-a></a><h3 class=section-title>Early initiation of HAART</h3><p class="" id=d16334e941>Lower HIV DNA levels in monocytes are associated with HAART initiation within the first year of infection, suggesting that the early commencement of HAART may improve outcomes in HAND<sup><a href="#ref-52">52</a>,<a href="#ref-139">139</a></sup>. However, the impact of immediate versus deterred HAART on neurocognitive performance in ARV-nave patients without profound immunosuppression is unclear. The recent INSIGHT START neurology substudy aimed to assess this<sup><a href="#ref-140">140</a>,<a href="#ref-141">141</a></sup>. Individuals were randomized to commence HAART either at baseline (CD4 &gt;500 cells/L) or when CD4<sup>+</sup> cells were below 350 cells/L<sup><a href="#ref-140">140</a></sup>. While serious AIDS and non-AIDS events were reduced in the immediate treatment arm, without increased adverse events, the neurocognitive substudy did not demonstrate similar improvements on neuropsychological tests<sup><a href="#ref-140">140</a>,<a href="#ref-141">141</a></sup>. However, less than 50% of the study population reached 4 years of follow-up, the potentially neurotoxic ARV, efavirenz, was commonly used<sup><a href="#ref-142">142</a></sup>, and low rates of HAND were found owing to short disease duration and high CD4<sup>+</sup> counts. As a result, further studies with longer duration of follow-up and adequate power are required to assess the feasibility of CNS protection with early ART initiation.</p></div><div class=section><a name=d16334e982 class=n-a></a><h3 class=section-title>Future treatment directions</h3><p class="" id=d16334e987>Current studies are investigating intranasal insulin, IL-1 antagonists, paroxetine, and complement inhibitors as well as limiting the replication of viral transcripts by Tat monoclonal antibodies and antisense oligonucleotides.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16334e994>Conclusion</h2><p class="" id=d16334e997>Recently, significant advances have been made in our understanding of HAND, facilitating further development of disease biomarkers and new treatments. Three key principles have become evident: selectivity (only some patients develop HAND), activity (HAND may fluctuate over months with some patients improving, a minority deteriorating, and a majority remaining stable), and a dynamic systemicbrain interface (some HAND patients appear to have the disease driven by systemic factors, while brain-related factors are important in others). Recognition of each of these will be needed to address the following questions:</p><div class=list><a name=d16334e1000 class=n-a></a><ul style="list-style-type: none"><li><p id=d16334e1007><span class=label>1. </span> In the context of earlier ART institution, adherence, and longstanding viral suppression, will the incidence of HAND remain as high? If so, does this reflect the effect of the viral reservoir and sanctuary, the self-perpetuating inflammatory cascade, or both?</p></li><li><p id=d16334e1016><span class=label>2. </span> Can screening tests and biomarkers be optimized to assess for early stages of HAND and can treatments prevent the progression to more severe subtypes?</p></li><li><p id=d16334e1025><span class=label>3. </span> Can early sensitive plasma, CSF, and imaging biomarkers of CNS impairment be used to improve therapeutic clinical trials? Can a combination of methods provide a more holistic concept of HAND pathogenesis? Can these methods be applied to patient care in the clinic?</p></li><li><p id=d16334e1034><span class=label>4. </span> Can the early institution of ARVs limit the development of the CNS reservoirs and prevent the inflammatory milieu from developing?</p></li><li><p id=d16334e1043><span class=label>5. </span> Can improved CNS penetration and efficacy, in particular with the use of maraviroc-enriched regimes, whilst maintaining systemic viral suppression, reduce the incidence of HAND?</p></li><li><p id=d16334e1053><span class=label>6. </span> Can novel cellular and molecular therapies, targeting recently understood pathogenic pathways, improve therapeutic efficacy?</p></li></ul></div><p class="" id=d16334e1058>Despite the inherent difficulties, large-scale, prospective, randomized trials with longitudinal follow-up, strict and consistent definitions of HAND, and adequate evaluation of comorbid conditions remain the best way to further our knowledge of HAND. This will allow us to evaluate biomarkers in screening and monitoring roles and adequately examine the effect of novel treatment regimens on cognitive function.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d16334e1 class=n-a></a><h2 class=main-title id=d16793>Competing interests</h2><p class=metadata-entry><a name=d16334e122 class=n-a></a><p id=d16334e124> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d16334e1 class=n-a></a><h2 class=main-title id=d16795>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d16334e1065 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d17274>References</h2><div class="section ref-list"><a name=d16334e1065 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d16334e1072 class=n-a></a>Gorman AA, Foley JM, Ettenhofer ML, <i> et al.</i>: Functional consequences of HIV-associated neuropsychological impairment. <i>Neuropsychol Rev.</i> 2009; <b>19</b>(2): 186203. <a target=xrefwindow id=d16334e1083 href="http://www.ncbi.nlm.nih.gov/pubmed/19472057">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1086 href="http://dx.doi.org/ 10.1007/s11065-009-9095-0">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1090 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2871666">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d16334e1099 class=n-a></a>Wilkie FL, Goodkin K, Eisdorfer C, <i> et al.</i>: Mild cognitive impairment and risk of mortality in HIV-1 infection. <i>J Neuropsychiatry Clin Neurosci.</i> 1998; <b>10</b>(2): 125132. <a target=xrefwindow id=d16334e1110 href="http://www.ncbi.nlm.nih.gov/pubmed/9608401">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1113 href="http://dx.doi.org/10.1176/jnp.10.2.125">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d16334e1122 class=n-a></a>Albert SM, Marder K, Dooneief G, <i> et al.</i>: Neuropsychologic impairment in early HIV infection. A risk factor for work disability. <i>Arch Neurol.</i> 1995; <b>52</b>(5): 525530. <a target=xrefwindow id=d16334e1133 href="http://www.ncbi.nlm.nih.gov/pubmed/7733849">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1136 href="http://dx.doi.org/10.1001/archneur.1995.00540290115027">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d16334e1145 class=n-a></a>Marcotte TD, Heaton RK, Wolfson T, <i> et al.</i>: The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. <i>J Int Neuropsychol Soc.</i> 1999; <b>5</b>(7): 579592. <a target=xrefwindow id=d16334e1156 href="http://www.ncbi.nlm.nih.gov/pubmed/10645701">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d16334e1165 class=n-a></a>Hinkin CH, Castellon SA, Durvasula RS, <i> et al.</i>: Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. <i>Neurology.</i> 2002; <b>59</b>(12): 19441950. <a target=xrefwindow id=d16334e1176 href="http://www.ncbi.nlm.nih.gov/pubmed/12499488">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1179 href="http://dx.doi.org/10.1212/01.WNL.0000038347.48137.67">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1183 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2871670">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d16334e1193 class=n-a></a>Wright EJ, Nunn M, Joseph J, <i> et al.</i>: NeuroAIDS in the Asia Pacific Region. <i>J Neurovirol.</i> 2008; <b>14</b>(6): 465473. <a target=xrefwindow id=d16334e1204 href="http://www.ncbi.nlm.nih.gov/pubmed/19031289">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1207 href="http://dx.doi.org/10.1080/13550280802235932">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d16334e1216 class=n-a></a>Heaton RK, Cysique LA, Jin H, <i> et al.</i>: Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. <i>J Neurovirol.</i> 2008; <b>14</b>(6): 536549. <a target=xrefwindow id=d16334e1227 href="http://www.ncbi.nlm.nih.gov/pubmed/18991068">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1230 href="http://dx.doi.org/10.1080/13550280802378880">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1234 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2889205">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d16334e1243 class=n-a></a>McArthur JC: HIV dementia: an evolving disease. <i>J Neuroimmunol.</i> 2004; <b>157</b>(12): 310. <a target=xrefwindow id=d16334e1251 href="http://www.ncbi.nlm.nih.gov/pubmed/15579274">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1254 href="http://dx.doi.org/10.1016/j.jneuroim.2004.08.042">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d16334e1263 class=n-a></a>Robertson KR, Smurzynski M, Parsons TD, <i> et al.</i>: The prevalence and incidence of neurocognitive impairment in the HAART era. <i>AIDS.</i> 2007; <b>21</b>(14): 19151921. <a target=xrefwindow id=d16334e1274 href="http://www.ncbi.nlm.nih.gov/pubmed/17721099">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1277 href="http://dx.doi.org/10.1097/QAD.0b013e32828e4e27">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d16334e1286 class=n-a></a>Sacktor N, Lyles RH, Skolasky R, <i> et al.</i>: HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 19901998. <i>Neurol.</i> 2001; <b>56</b>(2): 257260. <a target=xrefwindow id=d16334e1297 href="http://www.ncbi.nlm.nih.gov/pubmed/11160967">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1300 href="http://dx.doi.org/10.1212/WNL.56.2.257">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d16334e1309 class=n-a></a>Woods SP, Moore DJ, Weber E, <i> et al.</i>: Cognitive neuropsychology of HIV-associated neurocognitive disorders. <i>Neuropsychol Rev.</i> 2009; <b>19</b>(2): 152168. <a target=xrefwindow id=d16334e1320 href="http://www.ncbi.nlm.nih.gov/pubmed/19462243">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1323 href="http://dx.doi.org/10.1007/s11065-009-9102-5">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1327 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2690857">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d16334e1337 class=n-a></a>Cysique LA, Maruff P, Brew BJ: Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. <i>J Neurovirol.</i> 2004; <b>10</b>(6): 35057. <a target=xrefwindow id=d16334e1345 href="http://www.ncbi.nlm.nih.gov/pubmed/15765806">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1348 href="http://dx.doi.org/10.1080/13550280490521078">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d16334e1357 class=n-a></a>Simioni S, Cavassini M, Annoni JM, <i> et al.</i>: Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. <i>AIDS.</i> 2010; <b>24</b>(9): 12431250. <a target=xrefwindow id=d16334e1368 href="http://www.ncbi.nlm.nih.gov/pubmed/19996937">PubMed Abstract </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d16334e1377 class=n-a></a>Heaton RK, Clifford DB, Franklin DR Jr, <i> et al.</i>: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. <i>Neurol.</i> 2010; <b>75</b>(23): 20872096. <a target=xrefwindow id=d16334e1388 href="http://www.ncbi.nlm.nih.gov/pubmed/21135382">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1391 href="http://dx.doi.org/10.1212/WNL.0b013e318200d727">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2995535">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d16334e1404 class=n-a></a>Heaton RK, Grant I, Butters N, <i> et al.</i>: The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. <i>J Int Neuropsychol Soc.</i> 1995; <b>1</b>(3): 231251. <a target=xrefwindow id=d16334e1415 href="http://www.ncbi.nlm.nih.gov/pubmed/9375218">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1418 href="http://dx.doi.org/10.1017/S1355617700000230">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d16334e1427 class=n-a></a>Grant I, Atkinson JH, Hesselink JR, <i> et al.</i>: Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. <i>Ann Intern Med.</i> 1987; <b>107</b>(6): 828836. <a target=xrefwindow id=d16334e1438 href="http://www.ncbi.nlm.nih.gov/pubmed/3688675">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1441 href="http://dx.doi.org/10.7326/0003-4819-107-6-828">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d16334e1450 class=n-a></a>Heaton RK, Franklin DR, Ellis RJ, <i> et al.</i>: HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. <i>J Neurovirol.</i> 2011; <b>17</b>(1): 316. <a target=xrefwindow id=d16334e1461 href="http://www.ncbi.nlm.nih.gov/pubmed/21174240">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1464 href="http://dx.doi.org/10.1007/s13365-010-0006-1">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1468 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3032197">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d16334e1478 class=n-a></a>Cysique LA, Heaton RK, Kamminga J, <i> et al.</i>: HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research. <i>J Neurovirol.</i> 2014; <b>20</b>(3): 25868. <a target=xrefwindow id=d16334e1489 href="http://www.ncbi.nlm.nih.gov/pubmed/24696363">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1492 href="http://dx.doi.org/10.1007/s13365-014-0242-x">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4268870">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d16334e1505 class=n-a></a>Antinori A, Arendt G, Becker JT, <i> et al.</i>: Updated research nosology for HIV-associated neurocognitive disorders. <i>Neurol.</i> 2007; <b>69</b>(18): 17891799. <a target=xrefwindow id=d16334e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/17914061">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1519 href="http://dx.doi.org/10.1212/01.WNL.0000287431.88658.8b">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4472366">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d16334e1532 class=n-a></a>Van Sighem AI, Gras LA, Reiss P, <i> et al.</i>: Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. <i>AIDS.</i> 2010; <b>24</b>(10): 15271535. <a target=xrefwindow id=d16334e1543 href="http://www.ncbi.nlm.nih.gov/pubmed/20467289">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1546 href="http://dx.doi.org/10.1097/QAD.0b013e32833a3946">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d16334e1555 class=n-a></a>McArthur JC, Brew BJ, Nath A: Neurological complications of HIV infection. <i>Lancet Neurol.</i> 2005; <b>4</b>(9): 543555. <a target=xrefwindow id=d16334e1563 href="http://www.ncbi.nlm.nih.gov/pubmed/16109361">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1566 href="http://dx.doi.org/10.1016/S1474-4422(05)70165-4">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726212390"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e1575 class=n-a></a>Saylor D, Dickens AM, Sckator N, <i> et al.</i>: HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. <i>Nat Rev Neurol.</i> 2016; <b>12</b>(5): 309. <a target=xrefwindow id=d16334e1586 href="http://www.ncbi.nlm.nih.gov/pubmed/27080521">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1589 href="http://dx.doi.org/10.1038/nrneurol.2016.53">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726212390">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d16334e1602 class=n-a></a>Gott C, Gates T, Dermody N, <i> et al.</i>: Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. <i>PLoS One.</i> 2017; <b>12</b>(3): e0171887. <a target=xrefwindow id=d16334e1613 href="http://www.ncbi.nlm.nih.gov/pubmed/28264037">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1616 href="http://dx.doi.org/10.1371/journal.pone.0171887">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1620 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5338778">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d16334e1630 class=n-a></a>Lu GM, Brew BJ, Siefried KJ, <i> et al.</i>: Is the HIV Dementia Scale a reliable tool for assessing HIV-related neurocognitive decline? <i>J AIDS Clin Res.</i> 2013; <b>5</b>: 1000269. <a target=xrefwindow id=d16334e1641 href="http://dx.doi.org/10.4172/2155-6113.1000269">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d16334e1650 class=n-a></a>Brouillette MJ, Mayo N, Fellows LK, <i> et al.</i>: A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need? <i>AIDS.</i> 2015; <b>29</b>(8): 895902. <a target=xrefwindow id=d16334e1661 href="http://www.ncbi.nlm.nih.gov/pubmed/25291105">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1664 href="http://dx.doi.org/10.1097/QAD.0000000000000152">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1668 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4444425">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d16334e1677 class=n-a></a>Bloch M, Kamminga J, Jayewardene A, <i> et al.</i>: A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. <i>Clin Infect Dis.</i> 2016; <b>63</b>(5): 687693. <a target=xrefwindow id=d16334e1688 href="http://www.ncbi.nlm.nih.gov/pubmed/27325690">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1691 href="http://dx.doi.org/10.1093/cid/ciw399">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1695 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4981762">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d16334e1704 class=n-a></a>Gates TM, Cysique LA, Siefried KJ, <i> et al.</i>: Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. <i>AIDS.</i> 2016; <b>30</b>(4): 591600. <a target=xrefwindow id=d16334e1715 href="http://www.ncbi.nlm.nih.gov/pubmed/26825032">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1718 href="http://dx.doi.org/10.1097/QAD.0000000000000951">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726363637"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e1727 class=n-a></a>Brouillette MJ, Yuen T, Fellows LK, <i> et al.</i>: Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort using Group-Based Trajectory Analysis. <i>PLoS One.</i> 2016; <b>11</b>(5): e0155766. <a target=xrefwindow id=d16334e1738 href="http://www.ncbi.nlm.nih.gov/pubmed/27191850">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1741 href="http://dx.doi.org/10.1371/journal.pone.0155766">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4871455">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726363637">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d16334e1758 class=n-a></a>Valcour V, Shikuma C, Shiramizu B, <i> et al.</i>: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. <i>Neurology.</i> 2004; <b>63</b>(5): 8227. <a target=xrefwindow id=d16334e1769 href="http://www.ncbi.nlm.nih.gov/pubmed/15365130">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1772 href="http://dx.doi.org/10.1212/01.WNL.0000134665.58343.8D">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1382180">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d16334e1786 class=n-a></a>Bhaskaran K, Mussini C, Antinori A, <i> et al.</i>: Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. <i>Ann Neurol.</i> 2008; <b>63</b>(2): 213221. <a target=xrefwindow id=d16334e1797 href="http://www.ncbi.nlm.nih.gov/pubmed/17894380">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1800 href="http://dx.doi.org/10.1002/ana.21225">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718382421"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e1809 class=n-a></a>Grant I, Franklin DR Jr, Deutsch R, <i> et al.</i>: Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. <i>Neurology.</i> 2014; <b>82</b>(23): 20552062. <a target=xrefwindow id=d16334e1820 href="http://www.ncbi.nlm.nih.gov/pubmed/24814848">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1823 href="http://dx.doi.org/10.1212/WNL.0000000000000492">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1827 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4118496">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718382421">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d16334e1840 class=n-a></a>Mind Exchange Working Group: Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. <i>Clin Infect Dis.</i> 2013; <b>56</b>(7): 10041017. <a target=xrefwindow id=d16334e1848 href="http://www.ncbi.nlm.nih.gov/pubmed/23175555">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1851 href="http://dx.doi.org/10.1093/cid/cis975">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1854 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3657494">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d16334e1863 class=n-a></a>ASHM Antiretroviral Guidelines. Accessed Dec 20<sup>th</sup>, 2016. <a target=xrefwindow id=d16334e1868 href="http://arv.ashm.org.au/">Reference Source</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d16334e1877 class=n-a></a>British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-positive individuals. 2016; Accessed Dec 20th, 2016. <a target=xrefwindow id=d16334e1879 href="http://www.bhiva.org/documents/Guidelines/Monitoring/2016-BHIVA-Monitoring-Guidelines.pdf">Reference Source</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d16334e1888 class=n-a></a>EACS European AIDS Clinical Society Guidelines. Version 8.1. 2016. Accessed Dec 20th, 2016. <a target=xrefwindow id=d16334e1890 href="http://www.eacsociety.org/files/guidelines_8.1-english.pdf">Reference Source</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d16334e1900 class=n-a></a>Fois AF, Brew BJ: The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication. <i>Curr HIV/AIDS Rep.</i> 2015; <b>12</b>(2): 299303. <a target=xrefwindow id=d16334e1908 href="http://www.ncbi.nlm.nih.gov/pubmed/25869939">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1911 href="http://dx.doi.org/10.1007/s11904-015-0257-9">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d16334e1920 class=n-a></a>Zhu T, Muthui D, Holte S, <i> et al.</i>: Evidence for human immunodeficiency virus type 1 replication <i>in vivo</i> in CD14<sup>+</sup> monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. <i>J Virol.</i> 2002; <b>76</b>(2): 707716. <a target=xrefwindow id=d16334e1938 href="http://www.ncbi.nlm.nih.gov/pubmed/11752161">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1941 href="http://dx.doi.org/10.1128/JVI.76.2.707-716.2002">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1944 href="http://www.ncbi.nlm.nih.gov/pmc/articles/136806">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d16334e1953 class=n-a></a>Bacchus C, Cheret A, Avettand-Fenol V, <i> et al.</i>: A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection. <i>PLoS One.</i> 2013; <b>8</b>(5): e64219. <a target=xrefwindow id=d16334e1964 href="http://www.ncbi.nlm.nih.gov/pubmed/23691172">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1967 href="http://dx.doi.org/10.1371/journal.pone.0064219">Publisher Full Text </a> | <a target=xrefwindow id=d16334e1971 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3653877">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/722006288"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e1980 class=n-a></a>Campbell JH, Hearps AC, Martin GE, <i> et al.</i>: The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. <i>AIDS.</i> 2014; <b>28</b>(15): 21752187. <a target=xrefwindow id=d16334e1991 href="http://www.ncbi.nlm.nih.gov/pubmed/25144219">PubMed Abstract </a> | <a target=xrefwindow id=d16334e1994 href="http://dx.doi.org/10.1097/QAD.0000000000000408">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/722006288">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d16334e2007 class=n-a></a>He J, Chen Y, Farzan M, <i> et al.</i>: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. <i>Nature.</i> 1997; <b>385</b>(6617): 645649. <a target=xrefwindow id=d16334e2018 href="http://www.ncbi.nlm.nih.gov/pubmed/9024664">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2021 href="http://dx.doi.org/10.1038/385645a0">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d16334e2030 class=n-a></a>Lavi E, Strizki JM, Ulrich AM, <i> et al.</i>: CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. <i>Am J Pathol.</i> 1997; <b>151</b>(4): 10351042. <a target=xrefwindow id=d16334e2041 href="http://www.ncbi.nlm.nih.gov/pubmed/9327737">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1858037">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d16334e2054 class=n-a></a>Gray LR, Cowley D, Welsh C, <i> et al.</i>: CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies. <i>Mol Psychiatry.</i> 2016; <b>21</b>(4): 57484. <a target=xrefwindow id=d16334e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/26303660">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2068 href="http://dx.doi.org/10.1038/mp.2015.111">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4804184">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d16334e2081 class=n-a></a>Desplats P, Dumaop W, Smith D, <i> et al.</i>: Molecular and pathologic insights from latent HIV-1 infection in the human brain. <i>Neurology.</i> 2013; <b>80</b>(15): 14151423. <a target=xrefwindow id=d16334e2092 href="http://www.ncbi.nlm.nih.gov/pubmed/23486877">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2095 href="http://dx.doi.org/10.1212/WNL.0b013e31828c2e9e">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2099 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3662272">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d16334e2108 class=n-a></a>Thompson KA, Cherry CL, Bell JE, <i> et al.</i>: Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. <i>Am J Pathol.</i> 2011; <b>179</b>(4): 16239. <a target=xrefwindow id=d16334e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/21871429">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2122 href="http://dx.doi.org/10.1016/j.ajpath.2011.06.039">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2126 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3181362">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d16334e2135 class=n-a></a>Carroll-Anzinger D, Al-Harthi L: Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. <i>J Virol.</i> 2006; <b>80</b>(1): 5414. <a target=xrefwindow id=d16334e2143 href="http://www.ncbi.nlm.nih.gov/pubmed/16352578">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2146 href="http://dx.doi.org/10.1128/JVI.80.1.541-544.2006">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2149 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1317538">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d16334e2158 class=n-a></a>Churchill MJ, Wesselingh SL, Cowley D, <i> et al.</i>: Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. <i>Ann Neurol.</i> 2009; <b>66</b>(2): 2538. <a target=xrefwindow id=d16334e2169 href="http://www.ncbi.nlm.nih.gov/pubmed/19743454">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2172 href="http://dx.doi.org/10.1002/ana.21697">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d16334e2181 class=n-a></a>Takahashi K, Wesselingh SL, Griffin DE, <i> et al.</i>: Localization of HIV-1 in human brain using polymerase chain reaction/<i>in situ</i> hybridization and immunocytochemistry. <i>Ann Neurol.</i> 1996; <b>39</b>(6): 70511. <a target=xrefwindow id=d16334e2195 href="http://www.ncbi.nlm.nih.gov/pubmed/8651642">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2199 href="http://dx.doi.org/10.1002/ana.410390606">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d16334e2209 class=n-a></a>Sharer LR, Saito Y, Da Cunha A, <i> et al.</i>: <i>In situ</i> amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue. <i>Hum Pathol.</i> 1996; <b>27</b>(6): 6147. <a target=xrefwindow id=d16334e2223 href="http://www.ncbi.nlm.nih.gov/pubmed/8666375">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2227 href="http://dx.doi.org/10.1016/S0046-8177(96)90172-0">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d16334e2236 class=n-a></a>An SF, Groves M, Giometto B, <i> et al.</i>: Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/<i>in situ</i> hybridisation technique. <i>Acta Neuropathol.</i> 1999; <b>98</b>(5): 4817. <a target=xrefwindow id=d16334e2250 href="http://www.ncbi.nlm.nih.gov/pubmed/10541871">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2254 href="http://dx.doi.org/10.1007/s004010051113">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d16334e2263 class=n-a></a>Churchill MJ, Gorry PR, Cowley D, <i> et al.</i>: Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues. <i>J Neurovirol.</i> 2006; <b>12</b>(2): 14652. <a target=xrefwindow id=d16334e2274 href="http://www.ncbi.nlm.nih.gov/pubmed/16798676">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2277 href="http://dx.doi.org/10.1080/13550280600748946">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726197664"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e2286 class=n-a></a>Honeycutt JB, Wahl A, Baker C, <i> et al.</i>: Macrophages sustain HIV replication <i>in vivo</i> independently of T cells. <i>J Clin Invest.</i> 2016; <b>126</b>(4): 135366. <a target=xrefwindow id=d16334e2300 href="http://www.ncbi.nlm.nih.gov/pubmed/26950420">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2304 href="http://dx.doi.org/10.1172/JCI84456">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2307 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4811134">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726197664">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718490995"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e2320 class=n-a></a>Dahl V, Peterson J, Fuchs D, <i> et al.</i>: Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. <i>AIDS.</i> 2014; <b>28</b>(15): 22512258. <a target=xrefwindow id=d16334e2331 href="http://www.ncbi.nlm.nih.gov/pubmed/25022595">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2334 href="http://dx.doi.org/10.1097/QAD.0000000000000400">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2338 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4492794">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718490995">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726768857"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e2351 class=n-a></a>Gama L, Abreu CM, Shirk EN, <i> et al.</i>: Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. <i>AIDS.</i> 2017; <b>31</b>(1): 514. <a target=xrefwindow id=d16334e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/27898590">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2365 href="http://dx.doi.org/10.1097/QAD.0000000000001267">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5131686">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726768857">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d16334e2383 class=n-a></a>Chun TW, Davey RT Jr, Ostrowski M, <i> et al.</i>: Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. <i>Nat Med.</i> 2000; <b>6</b>(7): 75761. <a target=xrefwindow id=d16334e2394 href="http://www.ncbi.nlm.nih.gov/pubmed/10888923">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2397 href="http://dx.doi.org/10.1038/77481">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718206507"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e2406 class=n-a></a>Dahl V, Gisslen M, Hagberg L, <i> et al.</i>: An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. <i>J Infect Dis.</i> 2014; <b>209</b>(10): 161822. <a target=xrefwindow id=d16334e2417 href="http://www.ncbi.nlm.nih.gov/pubmed/24338353">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2420 href="http://dx.doi.org/10.1093/infdis/jit805">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2424 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3997583">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718206507">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d16334e2437 class=n-a></a>Burdo TH, Soulas C, Orzechowski K, <i> et al.</i>: Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. <i>PLoS Pathog.</i> 2010; <b>6</b>(4): e1000842. <a target=xrefwindow id=d16334e2448 href="http://www.ncbi.nlm.nih.gov/pubmed/20419144">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2451 href="http://dx.doi.org/10.1371/journal.ppat.1000842">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2455 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2855320">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d16334e2464 class=n-a></a>Pierson T, McArthur J, Siliciano RF: Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. <i>Annu Rev Immunol.</i> 2000; <b>18</b>: 665708. <a target=xrefwindow id=d16334e2472 href="http://www.ncbi.nlm.nih.gov/pubmed/10837072">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2475 href="http://dx.doi.org/10.1146/annurev.immunol.18.1.665">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d16334e2484 class=n-a></a>Valcour VG, Shiramizu BT, Sithinamsuwan P, <i> et al.</i>: HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. <i>Neurology.</i> 2009; <b>72</b>(11): 992998. <a target=xrefwindow id=d16334e2495 href="http://www.ncbi.nlm.nih.gov/pubmed/19289739">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2498 href="http://dx.doi.org/10.1212/01.wnl.0000344404.12759.83">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2502 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2677463">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d16334e2511 class=n-a></a>Shiramizu B, Gartner S, Williams A, <i> et al.</i>: Circulating proviral HIV DNA and HIV-associated dementia. <i>AIDS.</i> 2005; <b>19</b>(1): 4552. <a target=xrefwindow id=d16334e2522 href="http://www.ncbi.nlm.nih.gov/pubmed/15627032">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2525 href="http://dx.doi.org/10.1097/00002030-200501030-00005">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1557628">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d16334e2539 class=n-a></a>Cysique LA, Hey-Cunningham WJ, Dermody N, <i> et al.</i>: Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition. <i>PLoS One.</i> 2015; <b>10</b>(4): e0120488. <a target=xrefwindow id=d16334e2550 href="http://www.ncbi.nlm.nih.gov/pubmed/25853424">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2553 href="http://dx.doi.org/10.1371/journal.pone.0120488">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4390276">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d16334e2566 class=n-a></a>Weber C, Belge KU, von Hundelshausen P, <i> et al.</i>: Differential chemokine receptor expression and function in human monocyte subpopulations. <i>J Leukoc Biol.</i> 2000; <b>67</b>(5): 699704. <a target=xrefwindow id=d16334e2577 href="http://www.ncbi.nlm.nih.gov/pubmed/10811011">PubMed Abstract </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d16334e2586 class=n-a></a>Thieblemont N, Weiss L, Sadeghi HM, <i> et al.</i>: CD14<sup>low</sup>CD16<sup>high</sup>: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. <i>Eur J Immunol.</i> 1995; <b>25</b>(12): 34183424. <a target=xrefwindow id=d16334e2604 href="http://www.ncbi.nlm.nih.gov/pubmed/8566032">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2607 href="http://dx.doi.org/10.1002/eji.1830251232">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d16334e2616 class=n-a></a>Ellery PJ, Tippett E, Chiu YL, <i> et al.</i>: The CD16<sup>+</sup> monocyte subset is more permissive to infection and preferentially harbors HIV-1 <i>in vivo</i>. <i>J Immunol.</i> 2007; <b>178</b>(10): 65816589. <a target=xrefwindow id=d16334e2634 href="http://www.ncbi.nlm.nih.gov/pubmed/17475889">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2637 href="http://dx.doi.org/10.4049/jimmunol.178.10.6581">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d16334e2646 class=n-a></a>Jaworowski A, Kamwendo DD, Ellery P, <i> et al.</i>: CD16<sup>+</sup> monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with <i>Plasmodium falciparum</i> malaria and HIV-1 infection. <i>J Infect Dis.</i> 2007; <b>196</b>(1): 3842. <a target=xrefwindow id=d16334e2664 href="http://www.ncbi.nlm.nih.gov/pubmed/17538881">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2667 href="http://dx.doi.org/10.1086/518443">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d16334e2676 class=n-a></a>Berger G, Durand S, Fargier G, <i> et al.</i>: APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. <i>PLoS Pathog.</i> 2011; <b>7</b>(9): e1002221. <a target=xrefwindow id=d16334e2687 href="http://www.ncbi.nlm.nih.gov/pubmed/21966267">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2690 href="http://dx.doi.org/10.1371/journal.ppat.1002221">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3178557">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d16334e2704 class=n-a></a>Peng G, Greenwell-Wild T, Nares S, <i> et al.</i>: Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. <i>Blood.</i> 2007; <b>110</b>(1): 393400. <a target=xrefwindow id=d16334e2715 href="http://www.ncbi.nlm.nih.gov/pubmed/17371941">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2718 href="http://dx.doi.org/10.1182/blood-2006-10-051763">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1896122">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d16334e2731 class=n-a></a>Berger A, Sommer AF, Zwarg J, <i> et al.</i>: SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutires syndrome are highly susceptible to HIV-1 infection. <i>PLoS Pathog.</i> 2011; <b>7</b>(12): e1002425. <a target=xrefwindow id=d16334e2742 href="http://www.ncbi.nlm.nih.gov/pubmed/22174685">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2745 href="http://dx.doi.org/10.1371/journal.ppat.1002425">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2749 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3234228">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d16334e2758 class=n-a></a>Laguette N, Sobhian B, Casartelli N, <i> et al.</i>: SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. <i>Nature.</i> 2011; <b>474</b>(7353): 654657. <a target=xrefwindow id=d16334e2769 href="http://www.ncbi.nlm.nih.gov/pubmed/21613998">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2772 href="http://dx.doi.org/10.1038/nature10117">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3595993">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d16334e2785 class=n-a></a>Pulliam L, Gascon R, Stubblebine M, <i> et al.</i>: Unique monocyte subset in patients with AIDS dementia. <i>Lancet.</i> 1997; <b>349</b>(9053): 692695. <a target=xrefwindow id=d16334e2796 href="http://www.ncbi.nlm.nih.gov/pubmed/9078201">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2799 href="http://dx.doi.org/10.1016/S0140-6736(96)10178-1">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d16334e2808 class=n-a></a>Han J, Wang B, Han N, <i> et al.</i>: CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients. <i>J Acq Immun Def Synd.</i> 2009; <b>52</b>(2): 553559. <a target=xrefwindow id=d16334e2819 href="http://www.ncbi.nlm.nih.gov/pubmed/19950429">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2822 href="http://dx.doi.org/10.1097/QAI.0b013e3181c1d4fe">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d16334e2831 class=n-a></a>Gelman BB, Lisinicchia JG, Morgello S, <i> et al.</i>: Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. <i>J Acquir Immune Defic Syndr.</i> 2013; <b>62</b>(5): 487495. <a target=xrefwindow id=d16334e2842 href="http://www.ncbi.nlm.nih.gov/pubmed/23242157">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2845 href="http://dx.doi.org/10.1097/QAI.0b013e31827f1bdb">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3664102">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d16334e2859 class=n-a></a>Williams K, Westmoreland S, Greco J, <i> et al.</i>: Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. <i>J Clin Invest.</i> 2005; <b>115</b>(9): 25342545. <a target=xrefwindow id=d16334e2870 href="http://www.ncbi.nlm.nih.gov/pubmed/16110325">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2873 href="http://dx.doi.org/10.1172/JCI22953">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2877 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1187930">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d16334e2886 class=n-a></a>Campbell JH, Burdo TH, Autissier P, <i> et al.</i>: Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS. <i>PLoS One.</i> 2011; <b>6</b>(4): e18688. <a target=xrefwindow id=d16334e2897 href="http://www.ncbi.nlm.nih.gov/pubmed/21494695">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2900 href="http://dx.doi.org/10.1371/journal.pone.0018688">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3071838">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d16334e2913 class=n-a></a>Kusao I, Shiramizu B, Liang CY, <i> et al.</i>: Cognitive performance related to HIV-1-infected monocytes. <i>J Neuropsychiatry Clin Neurosci.</i> 2012; <b>24</b>(1): 7180. <a target=xrefwindow id=d16334e2924 href="http://www.ncbi.nlm.nih.gov/pubmed/22450616">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2927 href="http://dx.doi.org/10.1176/appi.neuropsych.11050109">Publisher Full Text </a> | <a target=xrefwindow id=d16334e2931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3335340">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d16334e2940 class=n-a></a>Fischer-Smith T, Croul S, Sverstiuk AE, <i> et al.</i>: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. <i>J Neurovirol.</i> 2001; <b>7</b>(6): 528541. <a target=xrefwindow id=d16334e2951 href="http://www.ncbi.nlm.nih.gov/pubmed/11704885">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2954 href="http://dx.doi.org/10.1080/135502801753248114">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d16334e2963 class=n-a></a>Kristiansen M, Graversen JH, Jacobsen C, <i> et al.</i>: Identification of the haemoglobin scavenger receptor. <i>Nature.</i> 2001; <b>409</b>(6817): 198201. <a target=xrefwindow id=d16334e2974 href="http://www.ncbi.nlm.nih.gov/pubmed/11196644">PubMed Abstract </a> | <a target=xrefwindow id=d16334e2977 href="http://dx.doi.org/10.1038/35051594">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d16334e2986 class=n-a></a>Weaver LK, Hintz-Goldstein KA, Pioli PA, <i> et al.</i>: Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. <i>J Leukoc Biol.</i> 2006; <b>80</b>(1): 2635. <a target=xrefwindow id=d16334e2997 href="http://www.ncbi.nlm.nih.gov/pubmed/16799153">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3000 href="http://dx.doi.org/10.1189/jlb.1205756">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d16334e3010 class=n-a></a>Hintz KA, Rassias AJ, Wardwell K, <i> et al.</i>: Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. <i>J Leukoc Biol.</i> 2002; <b>72</b>(4): 711717. <a target=xrefwindow id=d16334e3021 href="http://www.ncbi.nlm.nih.gov/pubmed/12377940">PubMed Abstract </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d16334e3030 class=n-a></a>Moller HJ, Peterslund NA, Graversen JH, <i> et al.</i>: Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. <i>Blood.</i> 2002; <b>99</b>(1): 378380. <a target=xrefwindow id=d16334e3041 href="http://www.ncbi.nlm.nih.gov/pubmed/11756196">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3044 href="http://dx.doi.org/10.1182/blood.V99.1.378">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d16334e3053 class=n-a></a>Back E, Schwarting R, Gerdes J, <i> et al.</i>: Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. <i>J Clin Pathol.</i> 1991; <b>44</b>(11): 93645. <a target=xrefwindow id=d16334e3064 href="http://www.ncbi.nlm.nih.gov/pubmed/1721628">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3067 href="http://dx.doi.org/10.1136/jcp.44.11.936">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3071 href="http://www.ncbi.nlm.nih.gov/pmc/articles/496636">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d16334e3080 class=n-a></a>Sulahian TH, Pioli PA, Wardwell K, <i> et al.</i>: Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163. <i>J Leukoc Biol.</i> 2004; <b>76</b>(1): 271277. <a target=xrefwindow id=d16334e3091 href="http://www.ncbi.nlm.nih.gov/pubmed/15075364">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3094 href="http://dx.doi.org/10.1189/jlb.1003523">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d16334e3103 class=n-a></a>Timmermann M, Hogger P: Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. <i>Free Radic Biol Med.</i> 2005; <b>39</b>(1): 98107. <a target=xrefwindow id=d16334e3111 href="http://www.ncbi.nlm.nih.gov/pubmed/15925282">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3114 href="http://dx.doi.org/10.1016/j.freeradbiomed.2005.02.031">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d16334e3123 class=n-a></a>Burdo TH, Lentz MR, Autissier P, <i> et al.</i>: Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. <i>J Infect Dis.</i> 2011; <b>204</b>(1): 154163. <a target=xrefwindow id=d16334e3134 href="http://www.ncbi.nlm.nih.gov/pubmed/21628670">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3137 href="http://dx.doi.org/10.1093/infdis/jir214">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3141 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3105035">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d16334e3151 class=n-a></a>Buechler C, Ritter M, Ors E, <i> et al.</i>: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and anti-inflammatory stimuli. <i>J Leukoc Biol.</i> 2000; <b>67</b>(1): 97103. <a target=xrefwindow id=d16334e3162 href="http://www.ncbi.nlm.nih.gov/pubmed/10648003">PubMed Abstract </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d16334e3171 class=n-a></a>Burdo TH, Weiffenbach A, Woods AP, <i> et al.</i>: Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. <i>AIDS.</i> 2013; <b>27</b>(9): 13871395. <a target=xrefwindow id=d16334e3182 href="http://www.ncbi.nlm.nih.gov/pubmed/23435298">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3185 href="http://dx.doi.org/10.1097/QAD.0b013e32836010bd">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3189 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3844286">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d16334e3198 class=n-a></a>Lyons JL, Uno H, Ancuta P, <i> et al.</i>: Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. <i>J Acquir Immune Defic Syndr.</i> 2011; <b>57</b>(5): 371379. <a target=xrefwindow id=d16334e3209 href="http://www.ncbi.nlm.nih.gov/pubmed/21646912">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3212 href="http://dx.doi.org/10.1097/QAI.0b013e3182237e54">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3216 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3159710">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d16334e3225 class=n-a></a>Sevigny JJ, Albert SM, McDermott MP, <i> et al.</i>: Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. <i>Neurology.</i> 2004; <b>63</b>(11): 20842090. <a target=xrefwindow id=d16334e3236 href="http://www.ncbi.nlm.nih.gov/pubmed/15596754">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3239 href="http://dx.doi.org/10.1212/01.WNL.0000145763.68284.15">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d16334e3248 class=n-a></a>Price RW, Epstein LG, Becker JT, <i> et al.</i>: Biomarkers of HIV-1 CNS infection and injury. <i>Neurology.</i> 2007; <b>69</b>(18): 17811788. <a target=xrefwindow id=d16334e3259 href="http://www.ncbi.nlm.nih.gov/pubmed/17967994">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3262 href="http://dx.doi.org/10.1212/01.wnl.0000278457.55877.eb">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d16334e3271 class=n-a></a>Freund A, Orjalo AV, Desprez PY, <i> et al.</i>: Inflammatory networks during cellular senescence: causes and consequences. <i>Trends Mol Med.</i> 2010; <b>16</b>(5): 238246. <a target=xrefwindow id=d16334e3282 href="http://www.ncbi.nlm.nih.gov/pubmed/20444648">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3285 href="http://dx.doi.org/10.1016/j.molmed.2010.03.003">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3289 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2879478">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d16334e3299 class=n-a></a>Cysique LA, Moffat K, Moore DM, <i> et al.</i>: HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: A <sup>1</sup>H MRS Study. <i>PLoS One.</i> 2013; <b>8</b>(4): e61738. <a target=xrefwindow id=d16334e3313 href="http://www.ncbi.nlm.nih.gov/pubmed/23620788">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3317 href="http://dx.doi.org/10.1371/journal.pone.0061738">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3631163">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d16334e3329 class=n-a></a>Yilmaz A, Price RW, Spudich S, <i> et al.</i>: Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. <i>J Acquir Immune Defic Syndr.</i> 2008; <b>47</b>(2): 16873. <a target=xrefwindow id=d16334e3340 href="http://www.ncbi.nlm.nih.gov/pubmed/17971711">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3343 href="http://dx.doi.org/10.1097/QAI.0b013e31815ace97">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3347 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2628632">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d16334e3356 class=n-a></a>Brew BJ, Dunbar N, Pemberton L, <i> et al.</i>: Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of <i></i><sub>2</sub>-microglobulin and neopterin. <i>J Infect Dis.</i> 1996; <b>174</b>(2): 294298. <a target=xrefwindow id=d16334e3372 href="http://www.ncbi.nlm.nih.gov/pubmed/8699058">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3376 href="http://dx.doi.org/10.1093/infdis/174.2.294">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725411277"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e3385 class=n-a></a>Beck SE, Queen SE, Witwer KW, <i> et al.</i>: Paving the path to HIV neurotherapy: predicting SIV CNS disease. <i>Eur J Pharmacol.</i> 2015; <b>759</b>: 303312. <a target=xrefwindow id=d16334e3396 href="http://www.ncbi.nlm.nih.gov/pubmed/25818747">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3399 href="http://dx.doi.org/10.1016/j.ejphar.2015.03.018">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3403 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4731094">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725411277">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d16334e3416 class=n-a></a>Brew BJ, Bhalla RB, Paul M, <i> et al.</i>: Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. <i>Ann Neurol.</i> 1990; <b>28</b>(4): 556560. <a target=xrefwindow id=d16334e3427 href="http://www.ncbi.nlm.nih.gov/pubmed/2252366">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3430 href="http://dx.doi.org/10.1002/ana.410280413">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d16334e3439 class=n-a></a>Roulston A, Lin R, Beauparlant P, <i> et al.</i>: Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. <i>Microbiol Rev.</i> 1995; <b>59</b>(3): 481505. <a target=xrefwindow id=d16334e3450 href="http://www.ncbi.nlm.nih.gov/pubmed/7565415">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3453 href="http://www.ncbi.nlm.nih.gov/pmc/articles/239370">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d16334e3463 class=n-a></a>Kasyanov A, Tamamura H, Fujii N, <i> et al.</i>: HIV-1 gp120 enhances giant depolarizing potentials via chemokine receptor CXCR4 in neonatal rat hippocampus. <i>Eur J Neurosci.</i> 2006; <b>23</b>(5): 11201128. <a target=xrefwindow id=d16334e3474 href="http://www.ncbi.nlm.nih.gov/pubmed/16553776">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3477 href="http://dx.doi.org/10.1111/j.1460-9568.2006.04646.x">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d16334e3486 class=n-a></a>Lu SM, Tremblay M, King IL, <i> et al.</i>: HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. <i>PLoS One.</i> 2011; <b>6</b>(9): e23915. <a target=xrefwindow id=d16334e3497 href="http://www.ncbi.nlm.nih.gov/pubmed/21912650">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3500 href="http://dx.doi.org/10.1371/journal.pone.0023915">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3504 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3166280">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d16334e3513 class=n-a></a>Power C, Hui E, Vivithanaporn P, <i> et al.</i>: Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr. <i>J Neuroimmune Pharmacol.</i> 2012; <b>7</b>(2): 319331. <a target=xrefwindow id=d16334e3524 href="http://www.ncbi.nlm.nih.gov/pubmed/21918813">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3527 href="http://dx.doi.org/10.1007/s11481-011-9310-7">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d16334e3536 class=n-a></a>Yang B, Akhter S, Chaudhuri A, <i> et al.</i>: HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. <i>Microvasc Res.</i> 2009; <b>77</b>(2): 212219. <a target=xrefwindow id=d16334e3547 href="http://www.ncbi.nlm.nih.gov/pubmed/19103208">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3550 href="http://dx.doi.org/10.1016/j.mvr.2008.11.003">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3554 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3715090">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725701865"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e3563 class=n-a></a>Wang T, Yi R, Green LA, <i> et al.</i>: Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. <i>Cardiovasc Pathol.</i> 2015; <b>24</b>(5): 279282. <a target=xrefwindow id=d16334e3574 href="http://www.ncbi.nlm.nih.gov/pubmed/26233281">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3577 href="http://dx.doi.org/10.1016/j.carpath.2015.07.001">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4831910">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725701865">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d16334e3594 class=n-a></a>Johnson TP, Patel K, Johnson KR, <i> et al.</i>: Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(33): 1358813593. <a target=xrefwindow id=d16334e3605 href="http://www.ncbi.nlm.nih.gov/pubmed/23898208">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3608 href="http://dx.doi.org/10.1073/pnas.1308673110">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3612 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3746932">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d16334e3622 class=n-a></a>Brew B, Cysique LA, Jones S, <i> et al.</i>: Detectable CSF Tat Despite Dual Compartment HIV Viral Suppression With cART. [Abstract 505] Presented at CROI, Seattle, WA, 2015. </span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d16334e3634 class=n-a></a>Henderson L, Johnspn T, Barclay R, <i> et al.</i>: Detection of HIV-1 Tat protein and TAR RNA in cerebrospinal fluid from patients on antiretroviral therapy: targeting persistent Tat production using antisense oligonucleotides. Poster 58 <i>14th International Symposium on NeuroVirology</i> October 2528, 2016, Toronto, Ontario, Canada. <i>J Neurovirol.</i> 2016; <b>22</b>(Suppl 1): S1S89. <a target=xrefwindow id=d16334e3648 href="http://dx.doi.org/10.1007/s13365-016-0478-8">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d16334e3657 class=n-a></a>Shieh JT, Albright AV, Sharron M, <i> et al.</i>: Chemokine receptor utilization by human immunodeficiency virus type 1 isolates that replicate in microglia. <i>J Virol.</i> 1998; <b>72</b>(5): 42434249. <a target=xrefwindow id=d16334e3668 href="http://www.ncbi.nlm.nih.gov/pubmed/9557714">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3671 href="http://www.ncbi.nlm.nih.gov/pmc/articles/109654">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d16334e3680 class=n-a></a>Albright AV, Shieh JT, Itoh T, <i> et al.</i>: Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. <i>J Virol.</i> 1999; <b>73</b>(1): 205213. <a target=xrefwindow id=d16334e3691 href="http://www.ncbi.nlm.nih.gov/pubmed/9847323">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3694 href="http://www.ncbi.nlm.nih.gov/pmc/articles/103824">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726085076"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e3703 class=n-a></a>Martin-Blondel G, Brassat D, Bauer J, <i> et al.</i>: CCR5 blockade for neuroinflammatory diseases--beyond control of HIV. <i>Nat Rev Neurol.</i> 2016; <b>12</b>(2): 95105. <a target=xrefwindow id=d16334e3714 href="http://www.ncbi.nlm.nih.gov/pubmed/26782333">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3717 href="http://dx.doi.org/10.1038/nrneurol.2015.248">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726085076">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d16334e3730 class=n-a></a>Gorry PR, Taylor J, Holm GH, <i> et al.</i>: Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. <i>J Virol.</i> 2002; <b>76</b>(12): 62776292. <a target=xrefwindow id=d16334e3741 href="http://www.ncbi.nlm.nih.gov/pubmed/12021361">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3744 href="http://dx.doi.org/10.1128/JVI.76.12.6277-6292.2002">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3748 href="http://www.ncbi.nlm.nih.gov/pmc/articles/136234">Free Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d16334e3758 class=n-a></a>Gonzlez-Scarano F, Martn-Garca J: The neuropathogenesis of AIDS. <i>Nat Rev Immunol.</i> 2005; <b>5</b>(1): 6981. <a target=xrefwindow id=d16334e3766 href="http://www.ncbi.nlm.nih.gov/pubmed/15630430">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3769 href="http://dx.doi.org/10.1038/nri1527">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d16334e3778 class=n-a></a>de Oliveira MF, Murell B, Prez-Santiago J, <i> et al.</i>: Circulating HIV DNA correlates with neurocognitive impairment in older HIV-infected adults on suppressive ART. <i>Sci Rep.</i> 2015; <b>5</b>: 17094. <a target=xrefwindow id=d16334e3789 href="http://www.ncbi.nlm.nih.gov/pubmed/26603568">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3792 href="http://dx.doi.org/10.1038/srep17094">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4658529">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d16334e3805 class=n-a></a>Garvey L, Surendrakumar V, Winston A: Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy. <i>HIV Clin Trials.</i> 2011; <b>12</b>(6): 333338. <a target=xrefwindow id=d16334e3813 href="http://www.ncbi.nlm.nih.gov/pubmed/22189152">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3816 href="http://dx.doi.org/10.1310/hct1206-333">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d16334e3825 class=n-a></a>Brew BJ, Pemberton L, Cunningham P, <i> et al.</i>: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. <i>J Infect Dis.</i> 1997; <b>175</b>(4): 963966. <a target=xrefwindow id=d16334e3836 href="http://www.ncbi.nlm.nih.gov/pubmed/9086160">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3839 href="http://dx.doi.org/10.1086/514001">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d16334e3848 class=n-a></a>Ellis RJ, Moore DJ, Childers ME, <i> et al.</i>: Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. <i>Arch Neurol.</i> 2002; <b>59</b>(6): 923928. <a target=xrefwindow id=d16334e3859 href="http://www.ncbi.nlm.nih.gov/pubmed/12056927">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3862 href="http://dx.doi.org/10.1001/archneur.59.6.923">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d16334e3871 class=n-a></a>Snnerborg AB, Ehrnst AC, Bergdahl SK, <i> et al.</i>: HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. <i>AIDS.</i> 1988; <b>2</b>(2): 8993. <a target=xrefwindow id=d16334e3882 href="http://www.ncbi.nlm.nih.gov/pubmed/3132952">PubMed Abstract </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d16334e3892 class=n-a></a>Canestri A, Lescure FX, Jaureguiberry S, <i> et al.</i>: Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. <i>Clin Infect Dis.</i> 2010; <b>50</b>(5): 773778. <a target=xrefwindow id=d16334e3903 href="http://www.ncbi.nlm.nih.gov/pubmed/20100092">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3906 href="http://dx.doi.org/10.1086/650538">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d16334e3915 class=n-a></a>Peluso MJ, Ferretti F, Peterson J, <i> et al.</i>: Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. <i>AIDS.</i> 2012; <b>26</b>(14): 17651774. <a target=xrefwindow id=d16334e3926 href="http://www.ncbi.nlm.nih.gov/pubmed/22614889">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3929 href="http://dx.doi.org/10.1097/QAD.0b013e328355e6b2">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3933 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3881435">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d16334e3942 class=n-a></a>Peluso MJ, Meyerhoff DJ, Price RW, <i> et al.</i>: Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. <i>J Infect Dis.</i> 2013; <b>207</b>(11): 17031712. <a target=xrefwindow id=d16334e3953 href="http://www.ncbi.nlm.nih.gov/pubmed/23460748">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3956 href="http://dx.doi.org/10.1093/infdis/jit088">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3960 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3636785">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727400023"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e3969 class=n-a></a>Gissln M, Price RW, Andreasson U, <i> et al.</i>: Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS injury in HIV infection: A Cross-Sectional Study. <i>EBioMedicine.</i> 2015; <b>3</b>: 13540. <a target=xrefwindow id=d16334e3980 href="http://www.ncbi.nlm.nih.gov/pubmed/26870824">PubMed Abstract </a> | <a target=xrefwindow id=d16334e3983 href="http://dx.doi.org/10.1016/j.ebiom.2015.11.036">Publisher Full Text </a> | <a target=xrefwindow id=d16334e3987 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4739412">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727400023">F1000 Recommendation</a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725393478"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e4000 class=n-a></a>McGuire JL, Gill AJ, Douglas SD, <i> et al.</i>: Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. <i>J Neurovirol.</i> 2015; <b>21</b>(4): 439448. <a target=xrefwindow id=d16334e4011 href="http://www.ncbi.nlm.nih.gov/pubmed/25776526">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4014 href="http://dx.doi.org/10.1007/s13365-015-0333-3">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4018 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4511078">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725393478">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d16334e4031 class=n-a></a>Gissln M, Hagberg L, Brew BJ, <i> et al.</i>: Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. <i>J Infect Dis.</i> 2007; <b>195</b>(12): 17741778. <a target=xrefwindow id=d16334e4042 href="http://www.ncbi.nlm.nih.gov/pubmed/17492593">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4045 href="http://dx.doi.org/10.1086/518043">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725289907"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e4055 class=n-a></a>Peterson J, Gisslen M, Zetterberg H, <i> et al.</i>: Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. <i>PLoS One.</i> 2014; <b>9</b>(12): e116081. <a target=xrefwindow id=d16334e4066 href="http://www.ncbi.nlm.nih.gov/pubmed/25541953">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4069 href="http://dx.doi.org/10.1371/journal.pone.0116081">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4277428">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725289907">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d16334e4086 class=n-a></a>Anesten B, Yilmaz A, Hagberg L, <i> et al.</i>: Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. <i>Neurol Neuroimmunol Neuroinflamm.</i> 2016; <b>3</b>(6): e300. <a target=xrefwindow id=d16334e4097 href="http://www.ncbi.nlm.nih.gov/pubmed/27868081">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4100 href="http://dx.doi.org/10.1212/NXI.0000000000000300">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4104 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5104266">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d16334e4113 class=n-a></a>Cysique LA, Hewitt T, Croitoru-Lamoury J, <i> et al.</i>: APOE 4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. <i>BMC Neurol.</i> 2015; <b>15</b>: 51. <a target=xrefwindow id=d16334e4124 href="http://www.ncbi.nlm.nih.gov/pubmed/25880550">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4127 href="http://dx.doi.org/10.1186/s12883-015-0298-0">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4386081">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726110713"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e4140 class=n-a></a>Calcagno A, Atzori C, Romito A, <i> et al.</i>: Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. <i>J Neurovirol.</i> 2016; <b>22</b>(1): 8892. <a target=xrefwindow id=d16334e4151 href="http://www.ncbi.nlm.nih.gov/pubmed/26246357">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4154 href="http://dx.doi.org/10.1007/s13365-015-0371-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726110713">F1000 Recommendation</a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727400027"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e4167 class=n-a></a>Ragin AB, Wu Y, Gao Y, <i> et al.</i>: Brain alterations within the first 100 days of HIV infection. <i>Ann Clin Transl Neurol.</i> 2015; <b>2</b>(1): 1221. <a target=xrefwindow id=d16334e4178 href="http://www.ncbi.nlm.nih.gov/pubmed/25642430">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4181 href="http://dx.doi.org/10.1002/acn3.136">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4185 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4301670">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727400027">F1000 Recommendation</a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d16334e4198 class=n-a></a>Pacifici M, Delbue S, Ferrante P, <i> et al.</i>: Cerebrospinal fluid miRNA profile in HIVencephalitis. <i>J Cell Physiol.</i> 2013; <b>228</b>(5): 10701075. <a target=xrefwindow id=d16334e4209 href="http://www.ncbi.nlm.nih.gov/pubmed/23042033">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4212 href="http://dx.doi.org/10.1002/jcp.24254">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4216 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3760673">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d16334e4226 class=n-a></a>Letendre SL, Ellis RJ, Deutsch R, <i> et al.</i>: Correlates of time-to-loss-of-viral-response in CSF and plasma in the CHARTER cohort. <i>17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA</i>, 2010; <b>430</b>. <a target=xrefwindow id=d16334e4237 href="https://charternntc.org/content/correlates-time-loss-viral-response-csf-and-plasma-charter-cohort">Reference Source</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d16334e4246 class=n-a></a>Letendre S, Marquie-Beck J, Capparelli E, <i> et al.</i>: Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. <i>Arch Neurol.</i> 2008; <b>65</b>(1): 6570. <a target=xrefwindow id=d16334e4257 href="http://www.ncbi.nlm.nih.gov/pubmed/18195140">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4260 href="http://dx.doi.org/10.1001/archneurol.2007.31">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4264 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2763187">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d16334e4273 class=n-a></a>Letendre SL, FitzSimons C, Ellis RJ, <i> et al.</i>: Correlates of CSF viral loads in 1,221 volunteers of the CHARTER Cohort. <i>17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA</i>, 2010; <b>172</b>. <a target=xrefwindow id=d16334e4284 href="https://publications.hivresearch.ucsd.edu/index.php?token=1a862931a4ee8bc54843961b332824e5&amp;sort_type=abs&amp;abstract_id=1453">Reference Source</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d16334e4293 class=n-a></a>Gray LR, Tachedjian G, Ellett AM, <i> et al.</i>: The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes. <i>PLoS One.</i> 2013; <b>8</b>(4): e62196. <a target=xrefwindow id=d16334e4304 href="http://www.ncbi.nlm.nih.gov/pubmed/23614033">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4307 href="http://dx.doi.org/10.1371/journal.pone.0062196">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3628669">Free Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d16334e4320 class=n-a></a>Cysique LA, Waters EK, Brew BJ: Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research. <i>BMC Neurol.</i> 2011; <b>11</b>: 148. <a target=xrefwindow id=d16334e4328 href="http://www.ncbi.nlm.nih.gov/pubmed/22107790">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4331 href="http://dx.doi.org/10.1186/1471-2377-11-148">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4334 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3252248">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d16334e4343 class=n-a></a>Ellis RJ, Letendre S, Vaida F, <i> et al.</i>: Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. <i>Clin Infect Dis.</i> 2014; <b>58</b>(7): 10151022. <a target=xrefwindow id=d16334e4354 href="http://www.ncbi.nlm.nih.gov/pubmed/24352352">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4357 href="http://dx.doi.org/10.1093/cid/cit921">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4361 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3952601">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d16334e4371 class=n-a></a>Secln E, del Mar Gonzlez M, Lapaz M, <i> et al.</i>: Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients. <i>J Antimicrob Chemother.</i> 2010; <b>65</b>(12): 25022504. <a target=xrefwindow id=d16334e4382 href="http://www.ncbi.nlm.nih.gov/pubmed/ 20940179">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4385 href="http://dx.doi.org/10.1093/jac/dkq381">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d16334e4394 class=n-a></a>Yilmaz A, Watson V, Else L, <i> et al.</i>: Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients. <i>AIDS.</i> 2009; <b>23</b>(18): 25372540. <a target=xrefwindow id=d16334e4405 href="http://www.ncbi.nlm.nih.gov/pubmed/19855252">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4408 href="http://dx.doi.org/10.1097/QAD.0b013e328333ae0e">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d16334e4417 class=n-a></a>Tiraboschi JM, Niubo J, Curto J, <i> et al.</i>: Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients. <i>J Acquir Immune Defic Syndr.</i> 2010; <b>55</b>(5): 606609. <a target=xrefwindow id=d16334e4428 href="http://www.ncbi.nlm.nih.gov/pubmed/20706127">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4431 href="http://dx.doi.org/10.1097/QAI.0b013e3181ef70fe">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d16334e4440 class=n-a></a>Kelly KM, Beck SE, Metcalf Pate KA, <i> et al.</i>: Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain. <i>AIDS.</i> 2013; <b>27</b>(18): F2128. <a target=xrefwindow id=d16334e4451 href="http://www.ncbi.nlm.nih.gov/pubmed/24051706">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4454 href="http://dx.doi.org/10.1097/QAD.0000000000000074">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4458 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4235167">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d16334e4467 class=n-a></a>Melica G, Canestri A, Peytavin G, <i> et al.</i>: Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms. <i>AIDS.</i> 2010; <b>24</b>(13): 21302133. <a target=xrefwindow id=d16334e4478 href="http://www.ncbi.nlm.nih.gov/pubmed/20601852">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4481 href="http://dx.doi.org/10.1097/QAD.0b013e32833c9353">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d16334e4490 class=n-a></a>Vera JH, Garvey LJ, Allsop JM, <i> et al.</i>: Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and <i>in vivo</i> metabolites measurable by magnetic resonance spectroscopy. <i>HIV Clin Trials.</i> 2012; <b>13</b>(4): 222227. <a target=xrefwindow id=d16334e4504 href="http://www.ncbi.nlm.nih.gov/pubmed/22849963">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4508 href="http://dx.doi.org/10.1310/hct1304-222">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d16334e4518 class=n-a></a>Johnson TP, Patel K, Johnson KR, <i> et al.</i>: Induction of IL-17 and nonclassical T-cell activation by HIV-tat protein. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(33): 1358813593. <a target=xrefwindow id=d16334e4529 href="http://www.ncbi.nlm.nih.gov/pubmed/23898208">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4532 href="http://dx.doi.org/10.1073/pnas.1308673110">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3746932">Free Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d16334e4545 class=n-a></a>Murray JM, McBride K, Boesecke C, <i> et al.</i>: Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards. <i>AIDS.</i> 2012; <b>26</b>(5): 543550. <a target=xrefwindow id=d16334e4556 href="http://www.ncbi.nlm.nih.gov/pubmed/22410637">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4559 href="http://dx.doi.org/10.1097/QAD.0b013e328350fb3c">Publisher Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725658442"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16334e4568 class=n-a></a>INSIGHT START Study Group, Lundgren JD, Babiker AG, <i> et al.</i>: Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. <i>N Engl J Med.</i> 2015; <b>373</b>(9): 795807. <a target=xrefwindow id=d16334e4579 href="http://www.ncbi.nlm.nih.gov/pubmed/26192873">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4582 href="http://dx.doi.org/10.1056/NEJMoa1506816">Publisher Full Text </a> | <a target=xrefwindow id=d16334e4586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4569751">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725658442">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d16334e4599 class=n-a></a>Wright E, Grund B, Robertson K, <i> et al.</i>: Presented at Insight Meeting. <i>International AIDS Society Meeting.</i> Vancouver, 2015. </span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d16334e4614 class=n-a></a>Ciccarelli N, Fabbiani M, Di Giambenedetto S, <i> et al.</i>: Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. <i>Neurology.</i> 2011; <b>76</b>(16): 14039. <a target=xrefwindow id=d16334e4625 href="http://www.ncbi.nlm.nih.gov/pubmed/21502598">PubMed Abstract </a> | <a target=xrefwindow id=d16334e4628 href="http://dx.doi.org/10.1212/WNL.0b013e31821670fb">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-312.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-312.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Neurology, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <sup>2</sup> Peter Duncan Neurosciences Unit, St Vincent&rsquo;s Centre for Applied Medical Research, St Vincent&rsquo;s Hospital, Sydney, Australia<br/> <sup>3</sup> Department of HIV Medicine, St Vincent&rsquo;s Hospital, Level 4, Xavier Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <sup>4</sup> University of New South Wales, St. Vincent&rsquo;s Clinical School, Delacy Building, Victoria Street, Darlinghurst, Sydney, Australia<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-312/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Mar 2017, 6:312 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10651.1">https://doi.org/10.12688/f1000research.10651.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Carroll A and Brew B. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11478 data-id=10651 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10651.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-312/v1/pdf?article_uuid=ae3c5a43-46b5-46dd-823e-12eed64a5fd3" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10651.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Carroll A and Brew B. HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):312 (<a href="https://doi.org/10.12688/f1000research.10651.1" target=_blank>https://doi.org/10.12688/f1000research.10651.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10651 id=mobile-track-article-signin-10651 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10651?target=/articles/6-312.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11478 /> <input name=articleId type=hidden value=10651 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Avindra Nath</strong>, National Institute for Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Justin McArthur</strong>, Department of Neurology, Johns Hopkins University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Dana H Gabuzda</strong>, Dana-Farber Cancer Institute, Boston, USA; Department of Neurology, Harvard Medical School, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Ronald J Ellis</strong>, Department of Neurosciences, University of California San Diego, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Mar 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-312.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-312.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21338-21132></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=5136-21130></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21340-21131></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21339-21133></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-312/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Mar 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Avindra Nath</strong>, National Institute for Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Justin McArthur</strong>, Department of Neurology, Johns Hopkins University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Dana H Gabuzda</strong>, Dana-Farber Cancer Institute, Boston, USA; Department of Neurology, Harvard Medical School, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ronald J Ellis</strong>, Department of Neurosciences, University of California San Diego, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-312.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-312/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "HIV-associated neurocognitive disorders:...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-312/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-312/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-312/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Carroll A and Brew B');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-312/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-312",
            templates : {
                twitter : "HIV-associated neurocognitive disorders: recent advances in pathogenesis,.... Carroll A and Brew B, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-312/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10651/11478")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11478");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "21130": 0,
                           "21131": 0,
                           "21132": 0,
                           "21133": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "c0e7a1f0-eb1a-4838-b461-bae77ebc09a4";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-312.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-312.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-312.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-312.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-312.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>